AMERICAN SOCIETY OF CLINICAL ONCOLOGY: Form 990, tax year 2013

View the entire original 990 at ProPublica ↗

Organization: AMERICAN SOCIETY OF CLINICAL ONCOLOGY (EIN 13-6180380)
Tax period: 2013-01-01 to 2013-12-31
Filed: 2014-08-08
IRS object ID: 201422209349300007
Schema version: 2013v3.0
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule F
Schedule I
Schedule J
Schedule K
Schedule O
Schedule R

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2014-08-08T07:50:41-05:00	ReturnTs
Tax Period End	2013-12-31	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Field	Value	IRS element (for citing)
Preparer Firm EIN	521855942	PreparerFirmEIN

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	TATE AND TRYON	BusinessNameLine1

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	2021 L STREET NW SUITE 400	AddressLine1
City	WASHINGTON	City
State	DC	State
ZIP Code	20036	ZIPCode

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2013-01-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	136180380	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	AMERICAN SOCIETY OF CLINICAL ONCOLOGY INC	BusinessNameLine1

Field	Value	IRS element (for citing)
Business Name Control	AMER	BusinessNameControlTxt
Phone	5714831300	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD NO 800	AddressLine1
City	ALEXANDRIA	City
State	VA	State
ZIP Code	22314	ZIPCode

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	PAUL AINES	PersonNm
Person Title	CPA, CFO	PersonTitleTxt
Phone	5714831300	PhoneNum
Signature	2014-08-08	SignatureDt
Discuss With Paid Preparer	Yes (1)	DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	DEBORAH G KOSNETT	PreparerPersonNm
PTIN	P00290720	PTIN
Phone	2022932200	PhoneNum

Field	Value	IRS element (for citing)
Tax	2013	TaxYr
Build TS	2015-11-30 17:44:51Z	BuildTS

Form 990 IRS990

Doing Business As Name DoingBusinessAsName

Field	Value	IRS element (for citing)
Business Name Line1	ASCO	BusinessNameLine1

Field	Value	IRS element (for citing)
Principal Officer	ALLEN LICHTER MD	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD NO 800	AddressLine1
City	ALEXANDRIA	City
State	VA	State
ZIP Code	22314	ZIPCode

Field	Value	IRS element (for citing)
Gross Receipts	$170,422,642	GrossReceiptsAmt
Group Return For Affiliates	0	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	WWW.ASCO.ORG	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1964	FormationYr
Legal Domicile State	NY	LegalDomicileStateCd
Activity Or Mission	ASCO IS A PROFESSIONAL ONCOLOGY SOCIETY COMMITTED TO CONQUERING CANCER THROUGH RESEARCH, EDUCATION, CONTINUED FROM PAGE 1: PREVENTION AND DELIVERY OF HIGH QUALITY PATIENT CARE.	ActivityOrMissionDesc
Voting Members Governing Body	18	VotingMembersGoverningBodyCnt
Voting Members Independent	17	VotingMembersIndependentCnt
Total Employee	403	TotalEmployeeCnt
Total Volunteers	1200	TotalVolunteersCnt
Total Gross UBI	$14,383,866	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$3,403,799	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$9,951,001	PYContributionsGrantsAmt
CY Contributions Grants	$8,477,875	CYContributionsGrantsAmt
PY Program Service Revenue	$73,138,765	PYProgramServiceRevenueAmt
CY Program Service Revenue	$76,312,383	CYProgramServiceRevenueAmt
PY Investment Income	$4,566,995	PYInvestmentIncomeAmt
CY Investment Income	$6,859,928	CYInvestmentIncomeAmt
PY Other Revenue	$771,150	PYOtherRevenueAmt
CY Other Revenue	$1,351,743	CYOtherRevenueAmt
PY Total Revenue	$88,427,911	PYTotalRevenueAmt
CY Total Revenue	$93,001,929	CYTotalRevenueAmt
PY Grants And Similar Paid	$1,729,260	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$1,103,926	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$31,364,730	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$30,968,009	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$110,025	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$0	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$2,992,820	CYTotalFundraisingExpenseAmt
PY Other Expenses	$44,890,049	PYOtherExpensesAmt
CY Other Expenses	$47,687,206	CYOtherExpensesAmt
PY Total Expenses	$78,094,064	PYTotalExpensesAmt
CY Total Expenses	$79,759,141	CYTotalExpensesAmt
PY Revenues Less Expenses	$10,333,847	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	$13,242,788	CYRevenuesLessExpensesAmt
Total Assets BOY	$177,197,733	TotalAssetsBOYAmt
Total Assets EOY	$195,594,554	TotalAssetsEOYAmt
Total Liabilities BOY	$104,485,526	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$98,271,504	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$72,712,207	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$97,323,050	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	ASCO IS A PROFESSIONAL ONCOLOGY SOCIETY COMMITTED TO CONQUERING CANCER THROUGH RESEARCH, EDUCATION, PREVENTION AND DELIVERY OF HIGH QUALITY CARE.ASCO VISION STATEMENTS:-- ALL CANCER PATIENTS WILL HAVE LIFELONG ACCESS TO HIGH QUALITY, EFFECTIVE, AFFORDABLE AND COMPASSIONATE CARE.-- THE MOST ACCURATE CANCER INFORMATION WILL BE AVAILABLE SO THAT PATIENTS AND PHYSICIANS CAN MAKE INFORMED DECISIONS ABOUT CANCER PREVENTION AND TREATMENT.-- INFORMATION WE LEARN FROM EVERY PATIENT WILL BE USED TO ACCELERATE PROGRESS AGAINST CANCER.-- RESOURCES WILL EXIST TO ATTRACT THE BEST CLINICIANS AND INVESTIGATORS TO PROVIDE OPTIMAL PATIENT CARE AND TO CONDUCT TRANSFORMATIVE RESEARCH. --ASCO WILL BE RECOGNIZED AS THE MOST TRUSTED SOURCE OF CANCER INFORMATION WORLDWIDE.	MissionDesc
Significant New Program Srvc	0	SignificantNewProgramSrvcInd
Significant Change	0	SignificantChangeInd
Expense	$32,812,833	ExpenseAmt
Grant	$422,256	GrantAmt
Revenue	$46,730,363	RevenueAmt
Desc	EDUCATIONAL AND SCIENTIFIC MEETINGS AND PRODUCTS AND PROFESSIONAL DEVELOPMENT: ASCO PROVIDES EDUCATIONAL AND SCIENTIFIC PROGRAMS AND CONTENT ON A VARIETY OF ONCOLOGY-RELATED TOPICS IN A VARIETY OF FORMATS. WORKING WITH VOLUNTEER ASCO MEMBERS, ASCO PLANS AND PRESENTS LIVE MEETINGS ON CUTTING EDGE RESEARCH AND SCIENCE IN THE FIELD OF CLINICAL ONCOLOGY. THE SCIENTIFIC RESEARCH AND EDUCATION PRESENTED AT THE MEETINGS ENHANCE KNOWLEDGE ABOUT CANCER, THUS ADVANCING HIGH-QUALITY CANCER CARE.THE ASCO ANNUAL MEETING IS THE WORLD'S PREMIER EDUCATIONAL AND SCIENTIFIC MEETING IN THE ONCOLOGY COMMUNITY AND THE THEMATIC MEETINGS PRESENTED OR CO-SPONSORED BY ASCO PROVIDE OPPORTUNITIES FOR FOCUSED EDUCATIONAL AND SCIENTIFIC PROGRAMMING ON SPECIFIC TYPES OF CANCERS. ASCO'S EDUCATIONAL AND SCIENTIFIC PROGRAMS SERVE THE DIVERSE EDUCATIONAL NEEDS OF ONCOLOGY PRACTITIONERS WORLDWIDE AND ASSIST THEM IN PROVIDING WORLD CLASS CANCER CARE AND IN CONDUCTING CUTTING EDGE RESEARCH THROUGH THE CONTINUUM OF THEIR CAREERS. APPROPRIATE PROGRAMS ARE PROVIDED FOR ONCOLOGY FELLOWS,JUNIOR FACULTY MEMBERS, ONCOLOGY PROGRAM DIRECTORS, AND OTHERS TO MEET THE CHANGING NEEDS OF PEOPLE LIVING WITH CANCER AND ADDRESS THE MODERN-DAY PRACTICE OF ONCOLOGY.WORKING WITH VOLUNTEER ASCO MEMBERS, ASCO PLANS, IMPLEMENTS AND EVALUATES CONTINUING MEDICAL EDUCATION (CME) TO SUPPORT THE CONTINUED EDUCATION OF ONCOLOGISTS SO THAT THEY ARE BETTER PREPARED TO MEET THE PREVENTION, DIAGNOSIS AND TREATMENT NEEDS OF THEIR PATIENTS. CURRENTLY, ASCO HOLDS THE STATUS OF ACCREDITATION WITH COMMENDATION FROM THE ACCREDITATION COUNCIL FOR CME FOR ASCO'S CME PROGRAM.ASCO MAKES MUCH OF THE CONTENT FROM ITS MEETINGS AND OTHER EDUCATIONAL AND SCIENTIFIC CONTENT AVAILABLE TO THE GENERAL PUBLIC THROUGH TWO ASCO WEBSITES: WWW.ASCO.ORG AND WWW.CANCER.NET. ADDITIONALLY, ASCO MAKES EDUCATIONAL AND SCIENTIFIC MATERIALS AVAILABLE THROUGH A VARIETY OF CHANNELS, INCLUDING BOOKS, DVDS, VIRTUAL MEETINGS, PODCASTS AND PUBLIC FORUMS.HIGHLIGHTS OF THE 2013 ACTIVITIES INCLUDE: OVER 32,000 PEOPLE ATTENDED THE 2013 ASCO ANNUAL MEETING, INCLUDING PHYSICIANS, NURSES, CAREGIVERS, PATIENTS, AND PATIENT ADVOCATES. MORE THAN HALF OF ATTENDEES AT THE 2013 ASCO ANNUAL MEETING WERE INTERNATIONAL ATTENDEES. THE 2013 ANNUAL MEETING FEATURED OVER 220 EDUCATIONAL AND SCIENTIFIC SESSIONS AND OVER 4,500 ABSTRACTS WERE PRESENTED OR PUBLISHED. NEARLY 3,000 PRESENTATIONS WERE CAPTURED IN AUDIO AND VIDEO TO BE MADE AVAILABLE ELECTRONICALLY.-IN 2013, ASCO HELD THREE "BEST OF ASCO" MEETINGS, WHICH COVERED THE MOST GROUND BREAKING SCIENCE RELEASED AT ASCO'S ANNUAL MEETING. OVER 1,200 ATTENDEES PARTICIPATED IN THESE MEETINGS.-IN 2013, ASCO OFFERED ITS SECOND QUALITY CARE SYMPOSIUM, WITH NEARLY 650 PEOPLE IN ATTENDANCE.-IN 2013, ASCO SPONSORED OR CO-SPONSORED OVER 50 EDUCATIONAL AND SCIENTIFIC SYMPOSIA, WORKSHOPS, AND COURSES INSIDE AND OUTSIDE THE UNITED STATES ON A WIDE VARIETY OF CANCER-RELATED TOPICS TO IMPROVE ONCOLOGY CARE IN AND AROUND THE WORLD, WHICH COLLECTIVELY DREW NEARLY 6,500 ATTENDEES. ALL 2013 ASCO MEETINGS AND SYMPOSIA WERE OPEN TO THE GENERAL PUBLIC. THESE MEETINGS INCLUDE:- ANNUAL MEETING- BEST OF ASCO CHICAGO- BEST OF ASCO BOSTON- BEST OF ASCO LOS ANGELES- ASCO'S QUALITY CARE SYMPOSIUM- GI CANCERS SYMPOSIUM- GU CANCERS SYMPOSIUM- BREAST CANCER SYMPOSIUM- ASCO/AACR METHODS IN CLINICAL CANCER RESEARCH WORKSHOPINTERNATIONAL AFFAIRS MEETINGS AND COURSES- BEST OF ASCO INTERNATIONAL (24)- JOINT SYMPOSIA (16)- ADVANCED CANCER COURSES (8)- MULTIDISCIPLINARY CANCER MANAGEMENT COURSES (4)ASCO PUBLISHES DAILY NEWS PRODUCTS FOR EACH OF ITS MAJOR LIVE MEETINGS. THE DAILY NEWS PRODUCTS INCLUDE PRINT NEWSPAPERS THAT ARE DISTRIBUTED ONSITE TO ALL ATTENDEES AT THE LIVE EVENT AND ONLINE (THE ENTIRETY OF THE PRINT VERSIONS PLUS ENHANCED COVERAGE) TO ASCO MEMBERS AND TO THE GENERAL PUBLIC. THE DAILY NEWS PRODUCTS INCLUDE COVERAGE OF KEY EDUCATIONAL AND SCIENTIFIC SESSIONS, EDITORIALS BY EXPERTS IN VARIOUS SUBSPECIALTIES, INFORMATION ABOUT ASCO PRODUCTS AND RESOURCES, PROFILES OF GRANT AND AWARD WINNERS, AND COMMENTARY AND TOPICS OF INTEREST TO INTERNATIONAL ATTENDEES AND MEMBERS.	Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

Field	Value	IRS element (for citing)
Expense	$10,670,552	ExpenseAmt
Grant	$138,150	GrantAmt
Revenue	$28,754,848	RevenueAmt
Desc	EDUCATIONAL PUBLICATIONS: ASCO PUBLISHES TWO EDUCATIONAL JOURNALS ADDRESSING CLINICAL ONCOLOGY THAT ARE AVAILABLE TO THE PUBLIC. JOURNAL OF CLINICAL ONCOLOGY (JCO) IS A HIGHLY REGARDED, PEER-REVIEWED JOURNAL THAT DISSEMINATES QUALITY ARTICLES ON SIGNIFICANT CLINICAL ONCOLOGY RESEARCH IN PRINT AND ELECTRONIC FORMATS. JOURNAL OF ONCOLOGY PRACTICE (JOP) INCLUDES ORIGINAL RESEARCH AND PERSPECTIVES ON CLINICAL AND ADMINISTRATIVE MANAGEMENT ADDRESSING THE PRACTICE OF ONCOLOGY, WHICH ARE EDITED BY ONCOLOGISTS. THE JOURNALS INCLUDE ORIGINAL REPORTS, SELECTED EDITORIALS, COMMENTARIES, REVIEWS, AND OTHER WORK THAT RELATES TO THE CARE OF PATIENTS WITH CANCER. JCO IS TRANSLATED INTO A NUMBER OF LANGUAGES IN INTERNATIONAL EDITIONS, THEREBY INCREASING ITS USE INTERNATIONALLY.-IN 2013 JOURNAL OF CLINICAL ONCOLOGY HAD 26,340 ANNUAL SUBSCRIBERS. ADDITIONALLY, AS REPORTED BY THOMSON REUTERS IN ITS 2011 JOURNAL CITATION REPORT, JCO'S IMPACT FACTOR OF 18.732 RANKED IT #53 OUT OF 8,336 JOURNALS MEASURED AND #5 IN THE ONCOLOGY CATEGORY (196 JOURNALS MEASURED). JCO RECEIVED 120,262 TOTAL CITATIONS IN 2011, WHICH RANKED IT #23 OVERALL AND #2 IN THE ONCOLOGY CATEGORY. JCO'S EIGENFACTOR SCORE OF 0.39463 (A MEASURE OF WHAT TYPES OF CITATIONS WERE GENERATED) RANKED IT #16 OVERALL AND #1 IN THE ONCOLOGY CATEGORY. THE IMPACT FACTOR, TOTAL CITATIONS, AND EIGENFACTOR SCORES ARE ALL REFLECTIONS OF THE VALUE RESEARCHERS FIND IN JCO CONTENT. ALL JCO ARTICLES ARE AVAILABLE FREE TO THE GENERAL PUBLIC ONE YEAR AFTER PUBLICATION. CERTAIN ARTICLES ARE AVAILABLE IMMEDIATELY, AND MANY ARTICLES ARE AVAILABLE THROUGH THE PUBLIC LIBRARY OF SCIENCE, A REPOSITORY OF SCIENTIFIC AND MEDICAL LITERATURE THAT IS FREELY ACCESSIBLE TO SCIENTISTS AND THE PUBLIC.IN 2013, JOURNAL OF ONCOLOGY PRACTICE (JOP) WAS ACCEPTED FOR INDEXING IN MEDLINE, THE PREMIER BIBLIOGRAPHIC DATABASE OF THE U.S. NATIONAL LIBRARY OF MEDICINE (NLM). THE INCLUSION OF JOP IN MEDLINE GIVES AN INDICATION OF ITS GROWING PROMINENCE AND REPUTATION IN ONCOLOGY AND IS A REFLECTION OF THE VERY HIGH QUALITY OF ITS PUBLISHED ARTICLES.	Desc

Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp

Field	Value	IRS element (for citing)
Expense	$7,612,826	ExpenseAmt
Grant	$19,250	GrantAmt
Revenue	$233,885	RevenueAmt
Desc	QUALITY: THE ASCO QUALITY DEPARTMENT IS RESPONSIBLE FOR THE DEVELOPMENT OF EVIDENCE-BASED GUIDELINES, DEVELOPING AND VALIDATING QUALITY MEASURES IN ONCOLOGY, QUALITY IMPROVEMENT AND MEASUREMENT.IN 2013, ASCO, WITH ITS RELATED ORGANIZATION, ASCO INSTITUTE FOR QUALITY, LLC, ENTERED THE ASSESSMENT PHASE OF CANCERLINQ, AN INITIATIVE TO DEVELOP A RAPID LEARNING SYSTEM IN ONCOLOGY. THIS EFFORT IS INTENDED TO TRANSFORM THE WAY ONCOLOGISTS PRACTICE, LEARN, AND INTERACT WITH THEIR PATIENTS. THE ASSESSMENT PHASE FOCUSES ON THE DEVELOPMENT OF A BREAST-CANCER SPECIFIC PROTOTYPE, WHICH WILL HELP DETERMINE AND OVERCOME THE BARRIERS IN DEVELOPING A FULL SYSTEM. PROGRAMS INCLUDE:- QUALITY ONCOLOGY PRACTICE INITIATIVE (QOPI), A VOLUNTARY QUALITY ASSESSMENT AND IMPROVEMENT PROGRAM FOR OUTPATIENT MEDICAL ONCOLOGY AND HEMATOLOGY-ONCOLOGY PRACTICES. QOPI PROVIDES A WEB-BASED DATA COLLECTION TOOL THAT ALLOWS PRACTICE STAFF TO 1) REPORT ON VARIOUS CANCER CARE QUALITY MEASURES, 2) RECEIVE ANALYZED DATA ON PRACTICE PERFORMANCE, AND 3) COMPARE PERFORMANCE AGAINST THEIR PEERS FOR DATA-DRIVEN IMPROVEMENT ACTIVITIES. THE PROGRAM IS UNIQUE IN THE CANCER COMMUNITY AND HAS BEEN ACCEPTED BY THE AMERICAN BOARD OF INTERNAL MEDICINE AS A MECHANISM FOR SATISFYING PRACTICE EVALUATION AND IMPROVEMENT REQUIREMENTS FOR MAINTENANCE OF CERTIFICATION. ASCO SUPPORTS A NUMBER OF COLLABORATIVE GROUPS THAT USE QOPI WITHIN THEIR INITIATIVES TO DRIVE THEIR QUALITY IMPROVEMENT EFFORTS. OVER 700 PRACTICES NATIONWIDE, INCLUDING PRACTICES IN HAWAII, ALASKA, GUAM, AND PUERTO RICO ARE ENROLLED IN THE PROGRAM.- QOPI CERTIFICATION PROGRAM. THE QOPI CERTIFICATION PROGRAM BUILDS UPON THE IMPACT OF QOPI. QOPI CERTIFICATION DEMONSTRATES A COMMITMENT TO EXCELLENCE AND ONGOING QUALITY IMPROVEMENT IN THE HEMATOLOGY-ONCOLOGY OUTPATIENT PRACTICE.THE GOALS OF THE QOPI CERTIFICATION PROGRAM ARE TO:- PROMOTE HIGH QUALITY CANCER CARE AS DEFINED BY THE CLINICIAN EXPERTS.- PROVIDE A TRUSTED SOLUTION TO SATISFY EXTERNAL DEMAND FOR QUALITY ACTIVITIES.- REDUCE REDUNDANT PROGRAMS RELATED TO THE DEMONSTRATION OF QUALITY. THE QOPI CERTIFICATION PROGRAM IS CARRIED OUT BY A SPECIAL-PURPOSE LIMITED LIABILITY CORPORATION (LLC), ASCO INSTITUTE FOR QUALITY, LLC (D/B/A QOPI CERTIFICATION PROGRAM). THE SOLE MEMBER OF THIS LLC IS ASCO AND THE PRESIDENT IS ASCO'S CHIEF EXECUTIVE OFFICER. NEW GUIDELINES AND ONGOING UPDATES. ASCO NOW HAS 39 PUBLISHED PRACTICE GUIDELINES, ENDORSEMENTS, AND PROVISIONAL CLINICAL OPINIONS (PCO'S) ADDRESSING A WIDE RANGE OF CANCER TREATMENT, DIAGNOSIS, AND MANAGEMENT ISSUES. AN ADDITIONAL 11 GUIDELINES ARE IN DEVELOPMENT, ALONG WITH 6 UPDATES TO EXISTING GUIDELINES. IN ADDITION, ASCO HAS ENDORSED 2 GUIDELINES DEVELOPED BY OUTSIDE ORGANIZATIONS.	Desc

Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp

Field	Value	IRS element (for citing)
Expense	$14,463,009	ExpenseAmt
Grant	$524,270	GrantAmt
Revenue	$593,287	RevenueAmt
Desc	CANCER POLICY AND CLINICAL AFFAIRS: ASCO'S CANCER POLICY AND CLINICAL AFFAIRS DEPARTMENT ADDRESSES POLICY ISSUES RAISED IN THE PRACTICE OF ONCOLOGY, CANCER RESEARCH, CARE AND PREVENTION. THE DEPARTMENT WORKS WITH VOLUNTEER COMMITTEES AND ASCO LEADERS TO SHAPE POLICY, LAW AND REGULATION ON ISSUES OF IMPORTANCE IN ONCOLOGY. THE DEPARTMENT'S PROGRAMS COVER A BROAD SPECTRUM OF ISSUES, INCLUDING PATIENT-ORIENTED RESEARCH, FEDERAL HEALTH PROGRAMS, CLINICAL PRACTICE, WORKFORCE, DISPARITIES, COST/ACCESS TO CARE, CANCER SURVIVORSHIP, AND CANCER PREVENTION AND CONTROL. ACTIVITIES INCLUDE HOTLINES, TOOLS, EDUCATIONAL WORKSHOPS AND MATERIALS, DEVELOPMENT OF FORMAL COMMENTS AND TESTIMONY, ADVOCACY, AND SPECIAL STUDIES ON CRITICAL ISSUES FOR THE CANCER COMMUNITY.CANCER POLICY AND CLINICAL AFFAIRS STAFF INTERACT AND COLLABORATE ON A REGULAR BASIS WITH ASCO STATE AND REGIONAL AFFILIATES, OTHER MEDICAL SPECIALTY AND PROFESSIONAL SOCIETIES, CONGRESS, THE ADMINISTRATION, AND PATIENT ADVOCATE ORGANIZATIONS TO ADVANCE COMMON GOALS RELATED TO CANCER RESEARCH AND QUALITY CARE.IN 2013, ASCO'S ACTIVITIES INCLUDED EFFORTS IN THE FOLLOWING AREAS:- BROAD EFFORTS TO BETTER STEWARD LIMITED HEALTH CARE RESOURCES INCLUDING ASCO PARTICIPATION IN SECOND ROUND OF THE AMERICAN BOARD OF INTERNAL MEDICINE'S "CHOOSING WISELY" CAMPAIGN, WHICH IS AIMED AT REDUCING OR ELIMINATING COMMONLY USED SERVICES THAT ARE OF QUESTIONABLE VALUE. ASCO'S COST OF CARE TASK FORCE COLLABORATES WITH QUALITY AND EDUCATION TEAMS TO DISSEMINATE RECOMMENDATIONS TO ONCOLOGISTS. ASCO CONTINUED ITS POLICY WORK IN 2013 BY ADDRESSING CANCER CARE AND RESEARCH ISSUES IN THE AREAS OF SURVIVORSHIP, TOBACCO USE, HEREDITARY CANCER RISK, AND CARE FOR PATIENTS WITH ADVANCED CANCER. ALSO, AS PART OF A COMPREHENSIVE EFFORT TO DETERMINE WORKFORCE CAPACITY TO MEET PROJECTED INCREASES IN CANCER INCIDENCE AND TO IDENTIFY INNOVATIVE CARE MODELS, ASCO STEWARDED A MULTI-PRONGED RESEARCH EFFORT TO ESTABLISH AN ONCOLOGY CENSUS, IDENTIFY TRENDS IN PRACTICE ECONOMICS, AND DOCUMENT CARE PATTERNS. ASCO WORKED WITH OTHER ADVOCACY GROUPS TO COMMUNICATE WITH THE DEPARTMENTS OF HEALTH AND HUMAN SERVICES, TREASURY, AND LABOR TO ENCOURAGE COMPREHENSIVE IMPLEMENTATION OF THE CLINICAL TRIALS COVERAGE PROVISION OF THE AFFORDABLE CARE ACT. FINALY, THE SOCIETY WORKED IN COLLABORATION WITH FDA AND OTHER ONCOLOGY STAKEHOLDERS TO REFINE CLINICAL ENDPOINTS USED IN CANCER CLINICAL TRIALS, OPTIMIZE DATA COLLECTION FOR SUPPLEMENTAL DRUG APPLICATIONS, AND TO ADDRESS THE ONGOING CHALLENGES PRESENTED BY PERSISTENT SHORTAGES OF CRITICAL CHEMOTHERAPY DRUGS.THE STATE/REGIONAL AFFILIATE PROGRAM:THE AFFILIATE PROGRAM WAS CREATED IN 1993 TO BETTER ADDRESS ISSUES RAISED IN THE PRACTICE OF ONCOLOGY, AND TO FACILITATE ASCO'S OWN ADVOCACY PROGRAMS. THE 48 STATE/REGIONAL AFFILIATES INTERACT WITH ASCO THROUGH THE STATE AFFILIATE COUNCIL, WHERE EACH SOCIETY HAS A VOTING REPRESENTATIVE CHARGED WITH SERVING AS THE BRIDGE BETWEEN THE SOCIETY AND ASCO. AFFILIATES HAVE ACCESS TO A NUMBER OF PROGRAMS INCLUDING STATE SOCIETY MEMBERSHIP RECRUITMENT AND RETENTION ASSISTANCE, LEADERSHIP TRAINING, FEDERAL-LEVEL ADVOCACY SUPPORT, EDUCATION AND RESOURCES ON PRACTICE-RELATED ISSUES, AND A WEBSITE DEVELOPMENT TOOL.FEDERAL POLICIES IMPACTING CANCER CARE AND RESEARCHASCO REVIEWS AND FREQUENTLY COMMENTS ON POLICIES ISSUED BY FEDERAL AGENCIES, INCLUDING THE CENTERS FOR MEDICARE & MEDICAID SERVICES (CMS), FOOD AND DRUG ADMINISTRATION (FDA), AND NATIONAL INSTITUTES OF HEALTH (NIH). STAFF AND VOLUNTEERS ALSO ACTIVELY PARTICIPATE IN AMERICAN MEDICAL ASSOCIATION (AMA) PROCESSES FOR DEVELOPMENT OF NEW CPT CODES AND VALUATION OF CODES THROUGH THE AMA/SPECIALTY SOCIETY RELATIVE VALUE SCALE UPDATE COMMITTEE (RUC).ORIGINAL DATA COLLECTIONASCO CONDUCTS STUDIES AND ANALYSES TO ASSESS THE CURRENT STATE OF ONCOLOGY CARE AND RESEARCH AND DETERMINE THE NEED FOR AND IMPACT OF POLICY CHANGES. IN 2013, ASCO COMPLETED A WORKFORCE CENSUS AND A COMPREHENSIVE ASSESSMENT OF EMERGING ONCOLOGY PRACTICE TRENDS. TO CLOSELY MONITOR THE RESEARCH AND PRACTICE ENVIRONMENTS AND PROVIDE AN IMPORTANT FOUNDATION FOR DETERMINING IMPACT OF CHANGES OCCURRING AS A RESULT OF HEALTHCARE REFORM IN THE UNITED STATES.MEMBER RELATIONS AND INFORMATIONASCO WORKS TO SUPPORT AND EDUCATE ITS MORE THAN 34,000 MEMBERS THROUGH ITS DAILY ACTIVITIES, INCLUDING PROCESSING NEW MEMBERSHIP APPLICATIONS AND MEMBER DUES, PHONE AND EMAIL COMMUNICATIONS, RESEARCHING AND ANSWERING MEMBER REQUESTS FOR INFORMATION, MAINTAINING THE INTEGRITY OF MEMBER DATA, AND NEW MEMBER RECRUITMENT AND RETENTION EFFORTS.ASCO CONNECTION IS THE OFFICIAL BIMONTHLY MEMBER MAGAZINE FOR AND ABOUT MEMBERS OF ASCO. IT IS THE PRIMARY SOURCE OF INFORMATION ABOUT ASCO'S PROGRAMS AND SERVICES. ALONG WITH ASCOCONNECTION.ORG, ASCO CONNECTION PROMOTES OPPORTUNITIES FOR INTERACTION BETWEEN ASCO AND ITS MEMBERS, AND MEMBERS AND THEIR COLLEAGUES, TO FACILITATE THE DISSEMINATION OF INFORMATION RELATING TO CUTTING EDGE RESEARCH, BEST PRACTICES STANDARDS, AND TREATMENT OF PATIENTS. ASCOCONNECTION.ORG FEATURES COMMENTARY BY LEADERS IN THE FIELD, DISCUSSION FORUMS, ONLINE EXCLUSIVES AND COMMENT-ENABLED ARTICLES FROM THE MEMBER MAGAZINE, AND OPPORTUNITIES TO CREATE GROUPS.COMMUNICATIONS AND PATIENT INFORMATION:ASCO PROVIDES THE PUBLIC, INCLUDING PATIENTS, THE MEDIA, LEGISLATORS, PHYSICIANS AND OTHER HEALTH CARE PROFESSIONALS WITH ACCURATE INFORMATION ABOUT CANCER, CANCER CARE, TREATMENT, RESEARCH, PREVENTION, AND OTHER ISSUES IMPORTANT TO THE CANCER COMMUNITY. ASCO HAS A FREE PATIENT EDUCATION WEBSITE, CANCER.NET (WWW.CANCER.NET), AVAILABLE TO THE PUBLIC, INCLUDING PATIENTS, THEIR CAREGIVERS, FAMILY MEMBERS AND FRIENDS, THE MEDIA, AND HEALTH CARE PROFESSIONALS THAT PROVIDES UP-TO-DATE INFORMATION ABOUT CANCER, CANCER CARE, TREATMENT, SURVIVORSHIP, RESEARCH, PREVENTION, AND OTHER ISSUES IMPORTANT TO THE CANCER COMMUNITY. THE SITE OFFERS MEDICAL INFORMATION ON MORE THAN 120 TYPES OF CANCER AND RELATED SYNDROMES, CLINICAL TRIALS, MANAGING SIDE EFFECTS, CAREGIVING, AND HOW TO COPE WITH THE EMOTIONAL AND SOCIAL EFFECTS OF LIVING WITH CANCER.IN ADDITION TO ITS WEBSITE CONTENT, ASCO OFFERS PRINTED MATERIALS FOR PATIENTS, SUCH AS: CANCER.NET'S GUIDES TO CANCER (DETAILED GUIDES COVERING SYMPTOMS, RISK FACTORS, DIAGNOSIS, STAGING, TREATMENT,CLINICAL TRIAL RESOURCES, SIDE EFFECTS, AFTER TREATMENT, CURRENT RESEARCH AND QUESTIONS TO ASK THE DOCTOR), ASCO ANSWERS FACT SHEETS (A SERIES OF FACT SHEETS THAT PROVIDE AN INTRODUCTION TO A SPECIFIC TYPE OF CANCER OR CANCER-RELATED TOPIC, INCLUDING AN OVERVIEW, AN ILLUSTRATION OF WHERE IT STARTS, HOW IT IS TREATED, TERMS TO KNOW, QUESTIONS TO ASK THE DOCTOR), AND BOOKLETS ON TOBACCO CESSATION, CANCER SURVIVORSHIP, ADVANCED CANCER CARE PLANNING, MANAGING THE COST OF CANCER CARE, AND CANCER IN OLDER ADULTS. ADDITIONAL RESOURCES AVAILABLE ON CANCER.NET.ASCO ALSO PROVIDES THE FOLLOWING INFORMATIONAL SERVICES TO THE PUBLIC:FIND AN ONCOLOGIST DATABASE: A FREE SEARCHABLE DATABASE OF ASCO MEMBERS BY SPECIALTY OR LOCATION FOR THOSE IN NEED OF A SPECIALIST. CANCER ADVANCES: SUMMARIES OF RESEARCH ADVANCES IN CLINICAL ONCOLOGY FROM THE JOURNAL OF CLINICAL ONCOLOGY, ASCO'S ANNUAL MEETINGS, AND ASCO SYMPOSIA.WHAT TO KNOW: ASCO'S GUIDELINES: PATIENT-FRIENDLY GUIDES BASED ON ASCO'S CLINICAL PRACTICE GUIDELINES FOR PHYSICIANS.RESEARCH AND MEETINGS: INFORMATION ON ASCO'S ANNUAL MEETINGS AND SYMPOSIA, VIRTUAL LECTURES, AND ASCO'S EXPERT PERSPECTIVE ON CANCER NEWS.MULTIMEDIA: MEDICAL ILLUSTRATIONS, MOBILE APPS, VIDEOS, AND PODCASTS ON TOPICS SUCH AS: CANCER RESEARCH, TREATMENT, AND COPING.EXPERT INFORMATION FROM ASCO: ASCO EXPERTS ANSWER QUESTIONS ABOUT CURRENT TOPICS IN CANCER CARE, TREATMENT, AND RESEARCH.CANCER.NET FEATURE ARTICLES: WEEKLY ARTICLES DESIGNED TO PROVIDE IN-DEPTH INFORMATION ON TOPICS OF INTEREST, AS WELL AS PRACTICAL INFORMATION ON CANCER CARE AND TREATMENT.ASCO CANCER TREATMENT SUMMARY FORMS: PRINTABLE FORMS PATIENTS AND THEIR DOCTORS CAN COMPLETE TO HELP KEEP TRACK OF TREATMENT PLANS AND FOLLOW-UP CARE PLANS.CANCER.NET EN ESPANOL: TRANSLATED CONTENT ON THE TREATMENT OF COMMON CANCER TYPES, MANAGING SIDE EFFECTS, AN INTRODUCTION TO CLINICAL TRIALS, SURVIVORSHIP, AND ASCO'S GUIDELINES. SEVERAL PRINTED PIECES ARE ALSO AVAILABLE IN SPANISH.	Desc

Field	Value	IRS element (for citing)
Total Other Prog Srvc Expense	$14,463,009	TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant	$524,270	TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue	$593,287	TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses	$65,559,220	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (1)	DescribedInSection501c3Ind
Schedule B Required	Yes (1)	ScheduleBRequiredInd
Political Campaign Acty	0	PoliticalCampaignActyInd
Lobbying Activities	Yes (1)	LobbyingActivitiesInd
Subject To Proxy Tax	0	SubjectToProxyTaxInd
Donor Advised Fund	0	DonorAdvisedFundInd
Conservation Easements	0	ConservationEasementsInd
Collections Of Art	0	CollectionsOfArtInd
Credit Counseling	0	CreditCounselingInd
Temp Or Permanent Endowments	0	TempOrPermanentEndowmentsInd
Report Land Building Equipment	Yes (1)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	Yes (1)	ReportInvestmentsOtherSecInd
Report Program Related Invst	0	ReportProgramRelatedInvstInd
Report Other Assets	0	ReportOtherAssetsInd
Report Other Liabilities	Yes (1)	ReportOtherLiabilitiesInd
Include FIN48 Footnote	Yes (1)	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	0	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	Yes (1)	ConsolidatedAuditFinclStmtInd
School Operating	0	SchoolOperatingInd
Foreign Office	Yes (1)	ForeignOfficeInd
Foreign Activities	Yes (1)	ForeignActivitiesInd
More Than5000 K To Org	Yes (1)	MoreThan5000KToOrgInd
More Than5000 K To Individuals	Yes (1)	MoreThan5000KToIndividualsInd
Professional Fundraising	0	ProfessionalFundraisingInd
Fundraising Activities	0	FundraisingActivitiesInd
Gaming Activities	0	GamingActivitiesInd
Operate Hospital	0	OperateHospitalInd
Grants To Organizations	Yes (1)	GrantsToOrganizationsInd
Grants To Individuals	0	GrantsToIndividualsInd
Schedule J Required	Yes (1)	ScheduleJRequiredInd
Tax Exempt Bonds	Yes (1)	TaxExemptBondsInd
Invest Tax Exempt Bonds	0	InvestTaxExemptBondsInd
Escrow Account	0	EscrowAccountInd
On Behalf Of Issuer	0	OnBehalfOfIssuerInd
Engaged In Excess Benefit Trans	0	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	0	PYExcessBenefitTransInd
Loan Outstanding	0	LoanOutstandingInd
Grant To Related Person	0	GrantToRelatedPersonInd
Business Rln With Org Mem	0	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	0	BusinessRlnWithFamMemInd
Business Rln With Officer Ent	0	BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri	0	DeductibleNonCashContriInd
Deductible Art Contribution	0	DeductibleArtContributionInd
Terminate Operations	0	TerminateOperationsInd
Partial Liquidation	0	PartialLiquidationInd
Disregarded Entity	Yes (1)	DisregardedEntityInd
Related Entity	Yes (1)	RelatedEntityInd
Related Organization Ctrl Ent	Yes (1)	RelatedOrganizationCtrlEntInd
Transaction With Control Ent	Yes (1)	TransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	0	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	0	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (1)	ScheduleORequiredInd
IRP Document	392	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (1)	BackupWthldComplianceInd
Employee	403	EmployeeCnt
Employment Tax Returns Filed	Yes (1)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	Yes (1)	UnrelatedBusIncmOverLimitInd
Form990 T Filed	Yes (1)	Form990TFiledInd
Foreign Financial Account	0	ForeignFinancialAccountInd
Prohibited Tax Shelter Trans	0	ProhibitedTaxShelterTransInd
Taxable Party Notification	0	TaxablePartyNotificationInd
Nondeductible Contributions	0	NondeductibleContributionsInd
Quid Pro Quo Contributions	0	QuidProQuoContributionsInd
Form8282 Property Disposed Of	0	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	0	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	0	PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services	0	IndoorTanningServicesInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	18	GoverningBodyVotingMembersCnt
Independent Voting Member	17	IndependentVotingMemberCnt
Family Or Business Rln	0	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	0	DelegationOfMgmtDutiesInd
Change To Org Documents	0	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	0	MaterialDiversionOrMisuseInd
Members Or Stockholders	Yes (1)	MembersOrStockholdersInd
Election Of Board Members	Yes (1)	ElectionOfBoardMembersInd
Decisions Subject To Approva	Yes (1)	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (1)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (1)	MinutesOfCommitteesInd
Officer Mailing Address	0	OfficerMailingAddressInd
Local Chapters	0	LocalChaptersInd
Form990 Provided To Gvrn Body	Yes (1)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (1)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (1)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (1)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (1)	WhistleblowerPolicyInd
Document Retention Policy	Yes (1)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (1)	CompensationProcessCEOInd
Compensation Process Other	Yes (1)	CompensationProcessOtherInd
Investment In Joint Venture	0	InvestmentInJointVentureInd
States Where Copy Of Return Is Fld	VA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NY	StatesWhereCopyOfReturnIsFldCd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	PAUL AINES CPA CFO	BusinessNameLine1

Field	Value	IRS element (for citing)
Phone	5714831300	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD 800	AddressLine1
City	ALEXANDRIA	City
State	VA	State
ZIP Code	22314	ZIPCode

Form990 Part VII Section A Form990PartVIISectionAGrp (31 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	OfficerOfficerInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	Key EmployeeKeyEmployeeInd	Highest Compensated EmployeeHighestCompensatedEmployeeInd
CLIFFORD HUDIS MD 09-12
PRESIDENT (12-13)	1.00	1.00	Yes (X)	Yes (X)	$0	$0	$0
PETER P YU MD 9-13
PRESIDENT ELECT (12-14)	1.00	0.00	Yes (X)	Yes (X)	$0	$0	$0
SANDRA M SWAIN MD
IMMED PAST PRES (13-14)	1.00	0.00	Yes (X)		$0	$0	$0
SUSAN L COHN MD 09-12
TREASURER (12-14)	1.00	0.00	Yes (X)	Yes (X)	$500	$0	$0
SMITA BHATIA MD
BOARD MEMBER (12-16)	1.00	0.00	Yes (X)		$1,500	$0	$0
GARY COHEN MD
BOARD MEMBER (11-14)	1.00	0.00	Yes (X)		$0	$0	$0
STEPHEN GRUBBS MD
BOARD MEMBER (12-15)	1.00	0.00	Yes (X)		$0	$0	$0
DANIEL HAYES MD
BOARD MEMBER (11-14)	1.00	0.00	Yes (X)		$0	$0	$0
PAULO HOFF MD
BOARD MEMBER (13-17)	1.00	0.00	Yes (X)		$0	$0	$0
HAGOP M KANTARJIAN MD
BOARD MEMBER (12-16)	1.00	0.00	Yes (X)		$0	$0	$0
GARY H LYMAN MD
BOARD MEMBER (12-16)	1.00	0.00	Yes (X)		$0	$0	$0
NEAL J MEROPOL MD
BOARD MEMBER (13-17)	1.00	0.00	Yes (X)		$500	$0	$0
THERESE M MULVEY MD
BOARD MEMBER (13-17)	1.00	0.00	Yes (X)		$0	$0	$0
LORI J PIERCE MD
BOARD MEMBER (10-14)	1.00	0.00	Yes (X)		$0	$0	$0
CAROLYN D RUNOWICZ MD
BOARD MEMBER (13-17)	1.00	0.00	Yes (X)		$0	$0	$0
FRANCES A SHEPHERD MD
BOARD MEMBER (10-14)	1.00	0.00	Yes (X)		$500	$0	$0
LILLIAN L SIU MD
BOARD MEMBER (12-16)	1.00	0.00	Yes (X)		$0	$0	$0
ERIC WINER MD
BOARD MEMBER (11-15)	1.00	0.00	Yes (X)		$0	$0	$0
W CHARLES PENLEY MD
CCF CHAIR (NONVOTING)	1.00	0.00	Yes (X)		$0	$0	$0
ALLEN LICHTER MD
CEO, EX OFFICIO DIRECTOR (NONVOTING)	33.50	4.00	Yes (X)	Yes (X)	$784,820	$0	$19,955
PAUL AINES CPA
CFO	33.50	4.00		Yes (X)	$317,000	$0	$35,301
DINA MICHELS ESQ
VICE PRES.,GEN COUNSEL,SEC	33.50	4.00		Yes (X)	$478,000	$0	$35,007
NANCY DALY MS MPH
EXEC DIRECTOR, CCF	1.00	36.50			$231,000	$0	$28,773	Yes (X)
JEAN COLVARD
S DIR MEMBER & MEETING SVS	37.50	0.00			$230,000	$0	$21,684	Yes (X)
DEBORAH KAMIN RN PHD
S DIR CANCER POLICY	37.50	0.00			$246,000	$0	$33,957	Yes (X)
BERNIE KHOO
S DIR INTEGRATED MEDIA	37.50	0.00			$380,481	$0	$35,301	Yes (X)
SUZANNE BRACH
S DIR MARKETING	37.50	0.00			$212,500	$0	$27,048		Yes (X)
KRISTIN LUDWIG
S DIR COMMUNICATIONS	37.50	0.00			$232,000	$0	$17,175		Yes (X)
KAY NOLL
S DIR HUMAN RESOURCES	37.50	0.00			$201,500	$0	$20,472		Yes (X)
ROBERT HAUSER PHARMD PHD
S DIR QUALITY	37.50	0.00			$274,750	$0	$35,301		Yes (X)
RICHARD SCHILSKY MD
CHIEF MEDICAL OFCR	37.50	0.00			$366,827	$0	$28,303		Yes (X)

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$3,957,878	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$0	TotReportableCompRltdOrgAmt
Total Other Compensation	$338,277	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	64	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	0	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (1)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	0	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1	CityContractorAddress/USAddress/City	StateContractorAddress/USAddress/State	ZIP CodeContractorAddress/USAddress/ZIPCode	ServicesServicesDesc	CompensationCompensationAmt
THE CORKERY GROUP
260 FIFTH AVE	NEW YORK	NY	10001	PUBLIC RELATIONS	$1,043,275
EKMAN ASSOCIATES
18735 SEABISCUIT RUN	YORBA LINDA	CA	92886	TECHNOLOGY CONSULTING	$582,500
MCDERMOTT WILL & EMERY LLP
PO BOX 6043	CHICAGO	IL	606806043	LEGAL	$459,798
ASTUTE TECHNOLOGY
11718 BOWMEN GREEN DR	RESTON	VA	20190	VIDEO RECORDING	$454,603
SAPIENT CORPORATION
PO BOX 4886	BOSTON	MA	02212	STRATEGY CONSULTING	$272,290

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	15	CntrctRcvdGreaterThan100KCnt
Related Organizations	$8,371,708	RelatedOrganizationsAmt
Government Grants	$56,167	GovernmentGrantsAmt
All Other Contributions	$50,000	AllOtherContributionsAmt
Total Contributions	$8,477,875	TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp (5 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt	Unrelated Business RevenueUnrelatedBusinessRevenueAmt
EDUCATION MTGS & PROD	900099	$25,592,471	$25,592,471
ADVERTISING	541800	$14,650,531		$14,650,531
PUBLICATIONS	511190	$14,104,317	$14,104,317
MEMBERSHIP	900099	$11,626,165	$11,626,165
EXHIBITS	900099	$9,511,727	$9,511,727

Total Oth Program Service Rev TotalOthProgramServiceRevGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$827,172	TotalRevenueColumnAmt
Related Or Exempt Func Income	$593,287	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$233,885	UnrelatedBusinessRevenueAmt

Field	Value	IRS element (for citing)
Total Program Service Revenue	$76,312,383	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$3,481,310	TotalRevenueColumnAmt
Exclusion	$3,481,310	ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$1,515,443	TotalRevenueColumnAmt
Exclusion	$1,515,443	ExclusionAmt

Gross Rents GrossRentsGrp

Field	Value	IRS element (for citing)
Real	$866,331	RealAmt

Less Rental Expenses LessRentalExpensesGrp

Field	Value	IRS element (for citing)
Real	$1,472,227	RealAmt

Rental Income Or Loss RentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Real	-$605,896	RealAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	-$605,896	TotalRevenueColumnAmt
Unrelated Business Revenue	-$605,896	UnrelatedBusinessRevenueAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

Field	Value	IRS element (for citing)
Securities	$79,327,104	SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

Field	Value	IRS element (for citing)
Securities	$75,948,486	SecuritiesAmt

Gain Or Loss GainOrLossGrp

Field	Value	IRS element (for citing)
Securities	$3,378,618	SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$3,378,618	TotalRevenueColumnAmt
Exclusion	$3,378,618	ExclusionAmt

Other Revenue Misc OtherRevenueMiscGrp (2 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	ExclusionExclusionAmt	Unrelated Business RevenueUnrelatedBusinessRevenueAmt
MAILING LIST	511120	$336,850	$336,850
OTHER	900099	$105,346		$105,346

Field	Value	IRS element (for citing)
Other Revenue Total	$442,196	OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$93,001,929	TotalRevenueColumnAmt
Related Or Exempt Func Income	$61,427,967	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$14,383,866	UnrelatedBusinessRevenueAmt
Exclusion	$8,712,221	ExclusionAmt

Field	Value	IRS element (for citing)
Info In Schedule O Part IX	Yes (X)	InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$641,269	TotalAmt
Program Services	$641,269	ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$462,657	TotalAmt
Program Services	$462,657	ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$4,026,131	TotalAmt
Program Services	$3,589,783	ProgramServicesAmt
Management And General	$436,348	ManagementAndGeneralAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$20,821,009	TotalAmt
Program Services	$16,774,140	ProgramServicesAmt
Management And General	$4,046,869	ManagementAndGeneralAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$1,661,592	TotalAmt
Program Services	$1,400,980	ProgramServicesAmt
Management And General	$260,612	ManagementAndGeneralAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$2,660,611	TotalAmt
Program Services	$2,350,409	ProgramServicesAmt
Management And General	$310,202	ManagementAndGeneralAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$1,798,666	TotalAmt
Program Services	$1,471,871	ProgramServicesAmt
Management And General	$326,795	ManagementAndGeneralAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$1,136,093	TotalAmt
Program Services	$437,545	ProgramServicesAmt
Management And General	$698,548	ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$134,350	TotalAmt
Program Services	$94,110	ProgramServicesAmt
Management And General	$28,823	ManagementAndGeneralAmt
Fundraising	$11,417	FundraisingAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$110,663	TotalAmt
Program Services	$110,663	ProgramServicesAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$666,260	TotalAmt
Management And General	$666,260	ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$10,948,280	TotalAmt
Program Services	$9,756,490	ProgramServicesAmt
Management And General	$1,156,497	ManagementAndGeneralAmt
Fundraising	$35,293	FundraisingAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$400,268	TotalAmt
Program Services	$367,719	ProgramServicesAmt
Management And General	$32,549	ManagementAndGeneralAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$1,807,486	TotalAmt
Program Services	$1,673,379	ProgramServicesAmt
Management And General	$119,325	ManagementAndGeneralAmt
Fundraising	$14,782	FundraisingAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$3,566,532	TotalAmt
Program Services	$2,768,106	ProgramServicesAmt
Management And General	$756,370	ManagementAndGeneralAmt
Fundraising	$42,056	FundraisingAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$4,736,417	TotalAmt
Program Services	$3,083,702	ProgramServicesAmt
Management And General	$1,311,467	ManagementAndGeneralAmt
Fundraising	$341,248	FundraisingAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$2,946,611	TotalAmt
Program Services	$2,630,848	ProgramServicesAmt
Management And General	$311,099	ManagementAndGeneralAmt
Fundraising	$4,664	FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$8,155,736	TotalAmt
Program Services	$7,688,831	ProgramServicesAmt
Management And General	$411,246	ManagementAndGeneralAmt
Fundraising	$55,659	FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$2,634,769	TotalAmt
Program Services	$2,104,186	ProgramServicesAmt
Management And General	$275,574	ManagementAndGeneralAmt
Fundraising	$255,009	FundraisingAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$439,382	TotalAmt
Program Services	$382,229	ProgramServicesAmt
Management And General	$29,684	ManagementAndGeneralAmt
Fundraising	$27,469	FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt	Management And GeneralManagementAndGeneralAmt	FundraisingFundraisingAmt
PRINTING & PRODUCTION	$4,331,857	$4,323,600	$3,641	$4,616
DEVELOPMENT FEE TO CCF	$2,199,996			$2,199,996
POSTAGE & SHIPPING	$1,791,043	$1,773,036	$17,862	$145
UBI TAX	$1,544,931	$1,544,874	$30	$27

All Other Expenses AllOtherExpensesGrp

Field	Value	IRS element (for citing)
Total	$136,532	TotalAmt
Program Services	$128,793	ProgramServicesAmt
Management And General	$7,300	ManagementAndGeneralAmt
Fundraising	$439	FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$79,759,141	TotalAmt
Program Services	$65,559,220	ProgramServicesAmt
Management And General	$11,207,101	ManagementAndGeneralAmt
Fundraising	$2,992,820	FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$300	BOYAmt
EOY	$300	EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$6,772,025	BOYAmt
EOY	$4,670,425	EOYAmt

Accounts Receivable AccountsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$4,394,111	BOYAmt
EOY	$4,931,658	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$3,001,853	BOYAmt
EOY	$2,893,602	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$67,539,246	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$13,267,564	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$55,800,602	BOYAmt
EOY	$54,271,682	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$104,851,167	BOYAmt
EOY	$113,771,697	EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$14,541,834	EOYAmt

Other Assets Total OtherAssetsTotalGrp

Field	Value	IRS element (for citing)
BOY	$2,377,675	BOYAmt
EOY	$513,356	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$177,197,733	BOYAmt
EOY	$195,594,554	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$5,034,542	BOYAmt
EOY	$4,603,669	EOYAmt

Deferred Revenue DeferredRevenueGrp

Field	Value	IRS element (for citing)
BOY	$16,686,023	BOYAmt
EOY	$18,956,773	EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$38,400,000	BOYAmt
EOY	$38,400,000	EOYAmt

Other Liabilities OtherLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$44,364,961	BOYAmt
EOY	$36,311,062	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$104,485,526	BOYAmt
EOY	$98,271,504	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows SFAS117	Yes (X)	OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$72,712,207	BOYAmt
EOY	$97,323,050	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$72,712,207	BOYAmt
EOY	$97,323,050	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$177,197,733	BOYAmt
EOY	$195,594,554	EOYAmt

Field	Value	IRS element (for citing)
Info In Schedule O Part XI	Yes (X)	InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss	$13,242,788	ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst	$3,314,156	NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets	$8,053,899	OtherChangesInNetAssetsAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	0	AccountantCompileOrReviewInd
FS Audited	Yes (1)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Consolidated Basis Fincl Stmt	Yes (X)	ConsolidatedBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (1)	AuditCommitteeInd
Federal Grant Audit Required	0	FederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Publicly Supported Org509a2	Yes (X)	PubliclySupportedOrg509a2Ind

Gifts Grants Contris Rcvd509 GiftsGrantsContrisRcvd509Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$9,749,125	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$8,931,139	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$7,731,584	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$9,951,001	CurrentTaxYearMinus1YearAmt
Current Tax Year	$8,371,708	CurrentTaxYearAmt
Total	$44,734,557	TotalAmt

Gross Receipts Admissions GrossReceiptsAdmissionsGrp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$57,163,871	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$61,001,326	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$61,722,689	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$60,750,073	CurrentTaxYearMinus1YearAmt
Current Tax Year	$64,619,271	CurrentTaxYearAmt
Total	$305,257,230	TotalAmt

Gross Receipts Non Unrlt Bus GrossReceiptsNonUnrltBusGrp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$155,397	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$235,462	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$386,588	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$345,882	CurrentTaxYearMinus1YearAmt
Current Tax Year	$336,850	CurrentTaxYearAmt
Total	$1,460,179	TotalAmt

Total509 Total509Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$67,068,393	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$70,167,927	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$69,840,861	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$71,046,956	CurrentTaxYearMinus1YearAmt
Current Tax Year	$73,327,829	CurrentTaxYearAmt
Total	$351,451,966	TotalAmt

Amounts Rcvd Dsqlfy Person AmountsRcvdDsqlfyPersonGrp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$13,762,781	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$12,940,190	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$10,563,934	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$13,094,217	CurrentTaxYearMinus1YearAmt
Current Tax Year	$11,456,835	CurrentTaxYearAmt
Total	$61,817,957	TotalAmt

Substantial Contributors Amt SubstantialContributorsAmtGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Subst And Dsqlfy Prsns Tot SubstAndDsqlfyPrsnsTotGrp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$13,762,781	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$12,940,190	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$10,563,934	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$13,094,217	CurrentTaxYearMinus1YearAmt
Current Tax Year	$11,456,835	CurrentTaxYearAmt
Total	$61,817,957	TotalAmt

Field	Value	IRS element (for citing)
Public Support Total509	$289,634,009	PublicSupportTotal509Amt

Gross Investment Income509 GrossInvestmentIncome509Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$1,248,387	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$848,971	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$3,354,163	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$3,987,722	CurrentTaxYearMinus1YearAmt
Current Tax Year	$4,996,753	CurrentTaxYearAmt
Total	$14,435,996	TotalAmt

Post1975 UBTI Post1975UBTIGrp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$1,445,377	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$2,794,100	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$1,677,713	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$1,888,008	CurrentTaxYearMinus1YearAmt
Current Tax Year	$2,246,507	CurrentTaxYearAmt
Total	$10,051,705	TotalAmt

Investment Income And UBTI InvestmentIncomeAndUBTIGrp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$2,693,764	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$3,643,071	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$5,031,876	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$5,875,730	CurrentTaxYearMinus1YearAmt
Current Tax Year	$7,243,260	CurrentTaxYearAmt
Total	$24,487,701	TotalAmt

Other Income509 OtherIncome509Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus1 Year	$73,056	CurrentTaxYearMinus1YearAmt
Total	$73,056	TotalAmt

Total Support Calendar Year TotalSupportCalendarYearGrp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$69,762,157	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$73,810,998	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$74,872,737	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$76,995,742	CurrentTaxYearMinus1YearAmt
Current Tax Year	$80,571,089	CurrentTaxYearAmt
Total	$376,012,723	TotalAmt

Field	Value	IRS element (for citing)
Public Support CY509	0.77030	PublicSupportCY509Pct
Public Support PY509	0.76710	PublicSupportPY509Pct
Investment Income CY	0.06510	InvestmentIncomeCYPct
Investment Income PY	0.05650	InvestmentIncomePYPct
Thirty Thr Pct Suprt Tests CY509	Yes (X)	ThirtyThrPctSuprtTestsCY509Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

Field	Value	IRS element (for citing)
Contributor	RESTRICTED	ContributorNum

Contributor Business Name ContributorBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor US Address ContributorUSAddress

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Total Contributions	RESTRICTED	TotalContributionsAmt

Schedule C IRS990ScheduleC

Total Grassroots Lobbying TotalGrassrootsLobbyingGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$12,065	FilingOrganizationsTotalAmt

Total Direct Lobbying TotalDirectLobbyingGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$158,414	FilingOrganizationsTotalAmt

Total Lobbying Expend TotalLobbyingExpendGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$170,479	FilingOrganizationsTotalAmt

Other Exempt Purpose Expend OtherExemptPurposeExpendGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$64,792,774	FilingOrganizationsTotalAmt

Total Exempt Purpose Expend TotalExemptPurposeExpendGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$64,963,253	FilingOrganizationsTotalAmt

Lobbying Nontaxable Amount LobbyingNontaxableAmountGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$1,000,000	FilingOrganizationsTotalAmt

Grassroots Nontaxable GrassrootsNontaxableGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$250,000	FilingOrganizationsTotalAmt

Tot Lbbyng Grassroot Mns Non Tx TotLbbyngGrassrootMnsNonTxGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$0	FilingOrganizationsTotalAmt

Tot Lbby Expend Mns Lbbyng Non Tx TotLbbyExpendMnsLbbyngNonTxGrp

Field	Value	IRS element (for citing)
Filing Organizations Total	$0	FilingOrganizationsTotalAmt

Avg Lobbying Nontaxable Amount AvgLobbyingNontaxableAmountGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$1,000,000	CurrentYearMinus3Amt
Current Year Minus2	$1,000,000	CurrentYearMinus2Amt
Current Year Minus1	$1,000,000	CurrentYearMinus1Amt
Current Year	$1,000,000	CurrentYearAmt
Total	$4,000,000	TotalAmt

Field	Value	IRS element (for citing)
Lobbying Ceiling	$6,000,000	LobbyingCeilingAmt

Avg Total Lobbying Expend AvgTotalLobbyingExpendGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$148,210	CurrentYearMinus3Amt
Current Year Minus2	$148,941	CurrentYearMinus2Amt
Current Year Minus1	$170,099	CurrentYearMinus1Amt
Current Year	$170,479	CurrentYearAmt
Total	$637,729	TotalAmt

Avg Grassroots Nontaxable AvgGrassrootsNontaxableGrp

Field	Value	IRS element (for citing)
Current Year Minus3	$250,000	CurrentYearMinus3Amt
Current Year Minus2	$250,000	CurrentYearMinus2Amt
Current Year Minus1	$250,000	CurrentYearMinus1Amt
Current Year	$250,000	CurrentYearAmt
Total	$1,000,000	TotalAmt

Field	Value	IRS element (for citing)
Grassroots Ceiling	$1,500,000	GrassrootsCeilingAmt

Avg Grassroots Lobbying Expend AvgGrassrootsLobbyingExpendGrp

Field	Value	IRS element (for citing)
Current Year Minus1	$1,320	CurrentYearMinus1Amt
Current Year	$12,065	CurrentYearAmt
Total	$13,385	TotalAmt

Schedule D IRS990ScheduleD

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$15,916	BeginningYearBalanceAmt
Grants Or Scholarships	$15,916	GrantsOrScholarshipsAmt

Land LandGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$7,342,677	OtherCostOrOtherBasisAmt
Book Value	$7,342,677	BookValueAmt

Buildings BuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$48,721,399	OtherCostOrOtherBasisAmt
Depreciation	$6,598,341	DepreciationAmt
Book Value	$42,123,058	BookValueAmt

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$11,475,170	OtherCostOrOtherBasisAmt
Depreciation	$6,669,223	DepreciationAmt
Book Value	$4,805,947	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Land Buildings	$54,271,682	TotalBookValueLandBuildingsAmt

Other Securities OtherSecuritiesGrp (2 entries)

DescDesc	Book ValueBookValueAmt	Method ValuationMethodValuationCd
ALPHAKEYS DOUBLE BLACK DIAMOND HEDGE FUND	$4,325,000	F
UBS MILLENNIUM FUND OFFSHORE LTD	$10,216,834	F

Field	Value	IRS element (for citing)
Total Book Value Securities	$14,541,834	TotalBookValueSecuritiesAmt

Other Liabilities Org OtherLiabilitiesOrgGrp (2 entries)

DescDesc	AmtAmt
LIABILITY UNDER INTEREST RATE SWAP AGREEMENT	$10,711,062
TAXABLE BOND PAYABLE	$25,600,000

Field	Value	IRS element (for citing)
Total Liability	$36,311,062	TotalLiabilityAmt
Footnote Text	Yes (X)	FootnoteTextInd
Total Rev Etc Audited Fincl Stmt	$105,175,951	TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst	$3,314,156	NetUnrealizedGainsInvstAmt
Other Revenue	$9,526,126	OtherRevenueAmt
Revenue Not Reported	$12,840,282	RevenueNotReportedAmt
Revenue Subtotal	$92,335,669	RevenueSubtotalAmt
Investment Expenses Not Incld	$666,260	InvestmentExpensesNotIncldAmt
Revenue Not Reported Fincl Stmt	$666,260	RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990	$93,001,929	TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt	$80,565,108	TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included	$1,472,227	OtherExpensesIncludedAmt
Expenses Not Reported	$1,472,227	ExpensesNotReportedAmt
Expenses Subtotal	$79,092,881	ExpensesSubtotalAmt
Investment Expenses Not Incld2	$666,260	InvestmentExpensesNotIncld2Amt
Expenses Not Rpt Fincl Stmt	$666,260	ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990	$79,759,141	TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
PART X, LINE 2:	THE ORGANIZATION BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN, AND THEREFORE, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE CONSOLIDATED FINANCIAL STATEMENTS. AT A MINIMUM, THE 2010 THROUGH 2013 TAX YEARS ARE OPEN FOR EXAMINATION BY TAXING AUTHORITIES.
PART XI, LINE 2D - OTHER ADJUSTMENTS:	GAIN ON VALUE OF INTEREST RATE SWAP 8,053,899. RENTAL EXPENSES TO PART VIII 1,472,227.
PART XII, LINE 2D - OTHER ADJUSTMENTS:	RENTAL EXPENSE TO PART VIII 1,472,227.

Schedule F IRS990ScheduleF

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (9 entries)

RegionRegionTxt	EmployeeEmployeeCnt	Type Of Activities ConductedTypeOfActivitiesConductedTxt	Specific Services ProvidedSpecificServicesProvidedTxt	Region Total ExpendituresRegionTotalExpendituresAmt
NORTH AMERICA	3	PROGRAM SERVICES	OUTREACH AND INTERNATIONAL CANCER EDUCATIONAL PROGRAMS	$9,984
EUROPE (INCLUDING ICELAND & GREENLAND)	0	PROGRAM SERVICES	OUTREACH AND INTERNATIONAL CANCER EDUCATIONAL PROGRAMS	$101,241
SOUTH AMERICA	0	PROGRAM SERVICES	OUTREACH AND INTERNATIONAL CANCER EDUCATIONAL PROGRAMS	$121,639
EAST ASIA AND THE PACIFIC	0	PROGRAM SERVICES	OUTREACH AND INTERNATIONAL CANCER EDUCATIONAL PROGRAMS	$28,923
MIDDLE EAST AND NORTH AFRICA	0	PROGRAM SERVICES	OUTREACH AND INTERNATIONAL CANCER EDUCATIONAL PROGRAMS	$35,689
SOUTH ASIA	0	PROGRAM SERVICES	OUTREACH AND INTERNATIONAL CANCER EDUCATIONAL PROGRAMS	$13,237
RUSSIA & THE NEWLY INDEPENDENT STATES	0	PROGRAM SERVICES	OUTREACH AND INTERNATIONAL CANCER EDUCATIONAL PROGRAMS	$28,606
SUB-SAHARAN AFRICA	0	PROGRAM SERVICES	OUTREACH AND INTERNATIONAL CANCER EDUCATIONAL PROGRAMS	$68,770
CENTRAL AMERICA AND THE CARIBBEAN	0	INVESTMENTS		$10,216,834

Field	Value	IRS element (for citing)
Subtotal Offices	0	SubtotalOfficesCnt
Subtotal Employees	3	SubtotalEmployeesCnt
Continutation Total Office	0	ContinutationTotalOfficeCnt
Continutation Total Employee	0	ContinutationTotalEmployeeCnt
Total Office	0	TotalOfficeCnt
Total Employee	3	TotalEmployeeCnt
Subtotal Spent	$408,089	SubtotalSpentAmt
Continuation Spent	$10,216,834	ContinuationSpentAmt
Total Spent	$10,624,923	TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (2 entries)

RegionRegionTxt	Purpose Of GrantPurposeOfGrantTxt	Cash GrantCashGrantAmt
EUROPE	CONTRIBUTION TO SUPPORT INTERNATIONAL CANCER CONTROL.	$13,368
EUROPE	CONTRIBUTION TO SUPPORT INTERNATIONAL CANCER CONTROL.	$40,800

Field	Value	IRS element (for citing)
Total501c3 Org	2	Total501c3OrgCnt
Total Other Org	0	TotalOtherOrgCnt

Foreign Individuals Grants ForeignIndividualsGrantsGrp (8 entries)

Type Of AssistanceTypeOfAssistanceTxt	RegionRegionTxt	RecipientRecipientCnt	Cash GrantCashGrantAmt	Manner Of Cash DisbursementMannerOfCashDisbursementTxt	Non Cash AssistanceNonCashAssistanceAmt	Description Of Non Cash AsstDescriptionOfNonCashAsstTxt	Valuation Method UsedValuationMethodUsedDesc
INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD	SOUTH ASIA	5	$5,600	CASH/CHECK	$21,367	IN-KIND TRAVEL SUPPORT FOR EDUCATION ON QUALITY CANCER CARE	BOOK
INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD	NORTH AMERICA	2	$2,200	CASH/CHECK	$4,567	IN-KIND TRAVEL SUPPORT FOR EDUCATION ON QUALITY CANCER CARE	BOOK
INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD	MIDDLE EAST AND NORTH AFRICA	5	$5,560	CASH/CHECK	$19,586	IN-KIND TRAVEL SUPPORT FOR EDUCATION ON QUALITY CANCER CARE	BOOK
INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD	EUROPE (INCLUDING ICELAND & GREENLAND)	1	$1,200	CASH/CHECK	$3,499	IN-KIND TRAVEL SUPPORT FOR EDUCATION ON QUALITY CANCER CARE	BOOK
INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD	RUSSIA & THE NEWLY INDEPENDENT STATES	2	$2,400	CASH/CHECK	$5,439	IN-KIND TRAVEL SUPPORT FOR EDUCATION ON QUALITY CANCER CARE	BOOK
INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD	EAST ASIA AND THE PACIFIC	4	$3,500	CASH/CHECK	$13,227	IN-KIND TRAVEL SUPPORT FOR EDUCATION ON QUALITY CANCER CARE	BOOK
INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD	SUB-SAHARAN AFRICA	4	$4,800	CASH/CHECK	$17,277	IN-KIND TRAVEL SUPPORT FOR EDUCATION ON QUALITY CANCER CARE	BOOK
INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD	SOUTH AMERICA	1	$1,100	CASH/CHECK	$3,804	IN-KIND TRAVEL SUPPORT FOR EDUCATION ON QUALITY CANCER CARE	BOOK

Field	Value	IRS element (for citing)
Transfer To Foreign Corp	Yes (1)	TransferToForeignCorpInd
Interest In Foreign Trust	0	InterestInForeignTrustInd
Foreign Corp Ownership	0	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	0	PassiveForeignInvestmestCoInd
Foreign Partnership	0	ForeignPartnershipInd
Boycott Countries	0	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 2:	FormAndLineReferenceDesc
Explanation	INTERNATIONAL DEVELOPMENT AND EDUCATION AWARD (IDEA) - THE INTERNATIONAL DEVELOPMENT AND EDUCATION AWARDS PROVIDE SUPPORT FOR EARLY-CAREER ONCOLOGISTS IN DEVELOPING COUNTRIES TO LEARN ABOUT ONCOLOGY CARE AND RESEARCH BY ESTABLISHING STRONG RELATIONSHIPS WITH LEADING ASCO ONCOLOGISTS WHO SERVE AS SCIENTIFIC MENTORS TO EACH RECIPIENT. RECIPIENTS LEARN ABOUT QUALITY CANCER CARE AND RESEARCH BY ATTENDING THE ASCO ANNUAL MEETING AND VISITING THEIR MENTOR'S CANCER CENTER IN THE UNITED STATES AND CANADA. RECIPIENTS ARE EXPECTED TO SHARE THE KNOWLEDGE AND TRAINING THEY RECEIVE THROUGH THE PROGRAM WITH COLLEAGUES IN THEIR HOME COUNTRIES ONCE THEY RETURN. IDEAS ARE PROVIDED TO RECIPIENTS BASED ON MERIT THROUGH A PEER REVIEW PROCESS OF REVIEW USING ESTABLISHED ELIGIBILITY CRITERIA. IDEA RECIPIENTS ARE REQUIRED TO AGREE TO TERMS AND CONDITIONS APPLICABLE TO THE IDEA, ARE REQUIRED TO COMMUNICATE WITH THEIR MENTORS, TO ATTEND ALL IDEA-RELATED EVENTS, AND TO SUBMIT EVALUATIONS AFTER THE ANNUAL MEETING AND MENTOR SITE VISIT AND SUBMIT ONE-YEAR REPORTS.	ExplanationTxt

Schedule I IRS990ScheduleI

Field	Value	IRS element (for citing)
Grant Records Maintained	Yes (1)	GrantRecordsMaintainedInd

Recipient Table RecipientTable (16 entries)

Address Line1USAddress/AddressLine1	CityUSAddress/City	StateUSAddress/State	ZIP CodeUSAddress/ZIPCode	Recipient EINRecipientEIN	IRC SectionIRCSectionDesc	Cash GrantCashGrantAmt	Purpose Of GrantPurposeOfGrantTxt
HEALTH VOLUNTEERS OVERSEAS
1900 L STREET NW 310	WASHINGTON	DC	20036	521485477	501(C)(3)	$5,000	CONTRIBUTION
FRIENDS OF CANCER RESEARCH
3299 K ST NW	WASHINGTON	DC	20007	521983273	501(C)(3)	$20,000	CONTRIBUTION
AMERICAN COLLEGE OF SURGEONS
633 NORTH ST CLAIR	CHICAGO	IL	60611	362192800	501(C)(3)	$125,000	CONTRIBUTION
NATIONAL ACADEMY OF SCIENCES
2101 CONSTITUTION AVENUE NW	WASHINGTON	DC	20418	530196932	501(C)(3)	$69,000	CONTRIBUTION
BROOKINGS INSTITUTION
1775 MASSACHUSETTS AVE	WASHINGTON	DC	20036	530196577	501(C)(3)	$10,000	CONTRIBUTION
WASHINGTON HOSPITAL CENTER-WASH CANCER INSTITUTE
110 IRVING ST NW	WASHINGTON	DC	20010	521272129	501(C)(3)	$14,194	CONTRIBUTION
KOMEN NAT'L RACE FOR THE CURE
1911 N FORT MYER DR 112	ARLINGTON	VA	22209	751835298	501(C)(3)	$25,000	CONTRIBUTION
CONQUER CANCER FOUNDATION
2318 MILL ROAD 800	ALEXANDRIA	VA	22314	311667995	501(C)(3)	$140,000	CONTRIBUTION
MEMORIAL SLOAN KETTERING CANCER CENTER
PO BOX 026338	NEW YORK	NY	10087	131924236	501(C)(3)	$113,555	CONTRIBUTION
CANCERCARE
275 7TH AVE	NEW YORK	NY	10001	131825919	501(C)(3)	$5,000	CONTRIBUTION
NATIONAL COALITION FOR CANCER SURVIVORSHIP
1010 WAYNE AVE 770	SILVER SPRING	MD	20910	850357897	501(C)(3)	$10,000	CONTRIBUTION
UNIVERSITY OF CHICAGO
1427 E 60TH SUITE 120	CHICAGO	IL	60637	362177139	501(C)(3)	$28,388	CONTRIBUTION
AMERICAN ASSOCIATION FOR CANCER RESEARCH
615 CHESTNUT STREET 17TH FLOOR	PHILADELPHIA	PA	19106	236251648	501(C)(3)	$5,000	CONTRIBUTION
DUKE UNIVERSITY MEDICAL CENTER
2424 ERWIN RD SUITE 601	DURHAM	NC	27705	560532129	501(C)(3)	$25,000	CONTRIBUTION
(no name)
							CONTRIBUTION
PALO ALTO MEDICAL FOUNDATION
795 EL CAMINO REAL	PALO ALTO	CA	94301	941156581	501(C)(3)	$46,132	CONTRIBUTION

Field	Value	IRS element (for citing)
Total501c3 Org	15	Total501c3OrgCnt
Total Other Org	0	TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART I, LINE 2:	FormAndLineReferenceDesc
Explanation	ASCO PROVIDES ASSISTANCE TO 501(C)(3) ORGANIZATIONS THAT SERVE THE CANCER COMMUNITY.	ExplanationTxt

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
Housing Allowance Or Residence	Yes (X)	HousingAllowanceOrResidenceInd
Written Policy Ref T And E Expnss	Yes (1)	WrittenPolicyRefTAndEExpnssInd
Substantiation Required	Yes (1)	SubstantiationRequiredInd
Compensation Committee	Yes (X)	CompensationCommitteeInd
Independent Consultant	Yes (X)	IndependentConsultantInd
Form990 Of Other Organizations	Yes (X)	Form990OfOtherOrganizationsInd
Written Employment Contract	Yes (X)	WrittenEmploymentContractInd
Compensation Survey	Yes (X)	CompensationSurveyInd
Board Or Committee Approval	Yes (X)	BoardOrCommitteeApprovalInd
Severance Payment	0	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	0	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	0	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	0	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	0	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	0	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	0	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	Yes (1)	AnyNonFixedPaymentsInd
Initial Contract Exception	Yes (1)	InitialContractExceptionInd
Rebuttable Presumption Proc	Yes (1)	RebuttablePresumptionProcInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (12 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
ALLEN LICHTER MD
CEO, EX OFFICIO DIRECTOR (NONVOTING)	$650,820	$0	$74,000	$0	$60,000	$0	$19,125	$0	$830	$0	$804,775	$0	$0	$0
PAUL AINES CPA
CFO	$312,000	$0	$5,000	$0	$0	$0	$19,125	$0	$16,176	$0	$352,301	$0	$0	$0
DINA MICHELS ESQ
VICE PRES.,GEN COUNSEL,SEC	$478,000	$0	$0	$0	$0	$0	$19,125	$0	$15,882	$0	$513,007	$0	$0	$0
NANCY DALY MS MPH
EXEC DIRECTOR, CCF	$231,000	$0	$0	$0	$0	$0	$17,325	$0	$11,448	$0	$259,773	$0	$0	$0
JEAN COLVARD
S DIR MEMBER & MEETING SVS	$227,000	$0	$3,000	$0	$0	$0	$16,025	$0	$5,659	$0	$251,684	$0	$0	$0
DEBORAH KAMIN RN PHD
S DIR CANCER POLICY	$241,000	$0	$5,000	$0	$0	$0	$18,075	$0	$15,882	$0	$279,957	$0	$0	$0
BERNIE KHOO
S DIR INTEGRATED MEDIA	$355,000	$0	$5,000	$0	$20,481	$0	$19,125	$0	$16,176	$0	$415,782	$0	$0	$0
SUZANNE BRACH
S DIR MARKETING	$208,000	$0	$4,500	$0	$0	$0	$15,600	$0	$11,448	$0	$239,548	$0	$0	$0
KRISTIN LUDWIG
S DIR COMMUNICATIONS	$229,000	$0	$3,000	$0	$0	$0	$17,175	$0	$0	$0	$249,175	$0	$0	$0
KAY NOLL
S DIR HUMAN RESOURCES	$197,500	$0	$4,000	$0	$0	$0	$14,813	$0	$5,659	$0	$221,972	$0	$0	$0
ROBERT HAUSER PHARMD PHD
S DIR QUALITY	$261,750	$0	$13,000	$0	$0	$0	$19,125	$0	$16,176	$0	$310,051	$0	$0	$0
RICHARD SCHILSKY MD
CHIEF MEDICAL OFCR	$366,827	$0	$0	$0	$0	$0	$19,125	$0	$9,178	$0	$395,130	$0	$0	$0

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
PART I, LINE 1A	A HOUSING ALLOWANCE IS PROVIDED TO THE CEO, WHICH IS CONSIDERED PART OF THE CEO'S COMPENSATION AND ADDRESSED IN THE CEO'S WRITTEN EMPLOYMENT CONTRACT. THE HOUSING ALLOWANCE IS TREATED AS TAXABLE COMPENSATION.
PART I, LINE 7	PERFORMANCE-BASED BONUS PAYMENTS CAN BE MADE TO SOME EMPLOYEES LISTED ON SCHEDULE J AND INCLUDED AS PART OF THE TOTAL COMPENSATION. THE BONUS PAYMENTS ARE NOT ON A FIXED BASIS BUT RATHER ARE BASED ON PERFORMANCE AND DETERMINED BY THE CEO WITH REVIEW AND APPROVAL BY THE COMPENSATION COMMITTEE OF THE BOARD, WHERE APPROPRIATE.
PART I, LINE 8	CERTAIN AMOUNTS PAID OR ACCRUED TO THE CEO AND THE VP/GC WERE PURSUANT TO A CONTRACT THAT WAS SUBJECT TO THE INITIAL CONTRACT EXCEPTION DESCRIBED IN TREAS. REGS. SECTION 53.4958-4(A)(3).

Schedule K IRS990ScheduleK

Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd

Issuer Name IssuerName

Field	Value	IRS element (for citing)
Business Name Line1	INDUSTRIAL DEVELOPMENT AUTHORITY CITY OF ALEXANDRIA	BusinessNameLine1

Field	Value	IRS element (for citing)
Bond Issuer EIN	521381432	BondIssuerEIN
CUSIP	01530LAD2	CUSIPNum
Bond Issued	2012-08-01	BondIssuedDt
Issue Price	$38,400,000	IssuePriceAmt
Purpose	BUY/BLDOUT 5 FLS HQ BLDG	PurposeDesc
Defeased	0	DefeasedInd
On Behalf Of Issuer	0	OnBehalfOfIssuerInd
Pool Financing	0	PoolFinancingInd

Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Total Proceeds	$38,400,000	TotalProceedsAmt
Capital Expenditures	$38,400,000	CapitalExpendituresAmt
Substantial Completion	2008	SubstantialCompletionYr
Current Refunding	0	CurrentRefundingInd
Advance Refunding	0	AdvanceRefundingInd
Final Allocation Made	Yes (1)	FinalAllocationMadeInd
Adequate Books And Rec Maint	Yes (1)	AdequateBooksAndRecMaintInd

Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Owning Bond Financed Property	0	OwningBondFinancedPropertyInd
Any Lease Arrangements	0	AnyLeaseArrangementsInd
Mgmt Contract Bond Fincd Prop	Yes (1)	MgmtContractBondFincdPropInd
Engage Bond Counsel Contracts	Yes (1)	EngageBondCounselContractsInd
Any Research Agreements	0	AnyResearchAgreementsInd
Private Bus Concerning UBI	0.00500	PrivateBusConcerningUBIPct
Total Private Business Use	0.00500	TotalPrivateBusinessUsePct
Bond Iss Meet Prvt Sec Pymt Test	0	BondIssMeetPrvtSecPymtTestInd
Change In Use Bond Financed Prop	0	ChangeInUseBondFinancedPropInd
Procs Nonqualified Bond Remdtd	Yes (1)	ProcsNonqualifiedBondRemdtdInd

Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Form8038 T Filed	0	Form8038TFiledInd
Rebate Not Due Yet	0	RebateNotDueYetInd
Exception To Rebate	0	ExceptionToRebateInd
No Rebate Due	0	NoRebateDueInd
Variable Rate Issue	Yes (1)	VariableRateIssueInd
Hedge Identified In Bks And Rec	Yes (1)	HedgeIdentifiedInBksAndRecInd

Hedge Provider Name HedgeProviderName

Field	Value	IRS element (for citing)
Business Name Line1	DEPFA BANK	BusinessNameLine1

Field	Value	IRS element (for citing)
Term Of Hedge	30.000000000000	TermOfHedgePct
Superintegrated Hedge	0	SuperintegratedHedgeInd
Hedge Terminated	0	HedgeTerminatedInd
Gross Proceeds Invested In GIC	0	GrossProceedsInvestedInGICInd
Gross Proceeds Invested	0	GrossProceedsInvestedInd
Written Proc To Monitor Reqs	Yes (1)	WrittenProcToMonitorReqsInd

Procedures Corrective Action ProceduresCorrectiveActionGrp

Field	Value	IRS element (for citing)
Bond Reference	A	BondReferenceCd
Procedures Corrective Action	Yes (1)	ProceduresCorrectiveActionInd

Supplemental Information Detail SupplementalInformationDetail

Field	Value	IRS element (for citing)
Form And Line Reference	PART IV, QUESTION 3:	FormAndLineReferenceDesc
Explanation	ASCO HAS AN INTEREST RATE SWAP AGREEMENT WITH DEPFA BANK THROUGH 2038. ASCO MAKES FIXED INTEREST PAYMENTS AT A 3.587% RATE. VARIABLE SWAP PAYMENTS, BASED ON ONE-MONTH LIBOR, RECEIVED FROM THE SWAP COUNTERPARTY ARE USED TO MAKE THE VARIABLE INTEREST PAYMENTS AS THEY COME DUE. THESE INTEREST RATE SWAP AGREEMENTS QUALIFY AS A DERIVATIVE INSTRUMENT AND ARE USED TO MITIGATE THE EFFECT OF INTEREST RATE FLUCTUATIONS.	ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (11 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
FORM 990, PART VI, SECTION A, LINE 1	AS OF DECEMBER 31, 2013, THE BOARD OF DIRECTORS OF ASCO INCLUDED 18 MEMBERS WITH THE RIGHT TO VOTE ON ALL MATTERS THAT COME BEFORE THE BOARD OF DIRECTORS. THE BOARD OF DIRECTORS ALSO INCLUDES TWO EX-OFFICIO DIRECTORS WITHOUT THE RIGHT TO VOTE, WHO ARE THE CHIEF EXECUTIVE OFFICER OF ASCO (CEO) AND THE CHAIR OF THE BOARD OF DIRECTORS OF CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (A NON-PROFIT, 501(C)(3) TAX EXEMPT RELATED ORGANIZATION OF ASCO). DURING THE REPORTING YEAR, THE BOARD OF DIRECTORS DELEGATED AUTHORITY TO ACT ON ITS BEHALF TO THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS, CONSISTENT WITH ASCO'S BYLAWS. DURING THE REPORTING YEAR, THE VOTING MEMBERS OF THE EXECUTIVE COMMITTEE WERE: THE PRESIDENT, PRESIDENT-ELECT, TREASURER, IMMEDIATE PAST-PRESIDENT, AND THOSE DIRECTORS SERVING THEIR FINAL YEAR OF THEIR BOARD TERMS. THE CEO IS A NON-VOTING MEMBER OF THE EXECUTIVE COMMITTEE. ALL EXECUTIVE COMMITTEE MEMBERS ARE MEMBERS OF ASCO'S BOARD OF DIRECTORS. THE SCOPE OF THE EXECUTIVE COMMITTEE'S AUTHORITY IS ESTABLISHED BY ASCO'S BYLAWS, WHICH PROVIDE THAT, EXCEPT TO THE EXTENT SPECIFICALLY PROHIBITED BY RESOLUTION OF THE BOARD OF DIRECTORS OR OTHERWISE PROHIBITED BY LAW, THE EXECUTIVE COMMITTEE OF THE BOARD IS EMPOWERED TO MAKE AND IMPLEMENT MAJOR DECISIONS BETWEEN BOARD MEETINGS AND IT MAY ACT ON ITEMS REQUIRING ACTION PRIOR TO THE NEXT ANNOUNCED BOARD MEETING. ALL ACTIONS OF THE EXECUTIVE COMMITTEE ARE REPORTED TO THE BOARD OF DIRECTORS AT THE NEXT MEETING OF THE BOARD OF DIRECTORS IMMEDIATELY FOLLOWING THE ACTION TAKEN BY THE EXECUTIVE COMMITTEE, CONSISTENT WITH ASCO'S BYLAWS.
FORM 990, PART VI, SECTION A, LINE 6	ASCO MEMBERS ARE ELECTED BY THE BOARD OF DIRECTORS, CONSISTENT WITH ASCO'S BYLAWS. NO MEMBER IS ENTITLED TO RECEIVE A SHARE OF ASCO'S PROFITS OR EXCESS DUES OR A SHARE OF ASCO'S NET ASSETS UPON DISSOLUTION. THE CATEGORIES OF MEMBERSHIP (WITH VOTING RIGHTS) AND SPECIFIED RIGHTS ARE AS FOLLOWS: 1. FULL MEMBERS. 1.A. FULL MEMBERS ARE (A) EXPERIENCED LICENSED PHYSICIANS OF ANY NATION WHO DEVOTE A MAJORITY OF THEIR PROFESSIONAL ACTIVITY TO CANCER PATIENT CARE AND/OR RESEARCH OR EDUCATION IN THE BIOLOGY, DIAGNOSIS, PREVENTION OR TREATMENT OF HUMAN CANCER (IN EXCEPTIONAL CASES, OTHER PHYSICIANS WHO HAVE MADE SIGNIFICANT CONTRIBUTIONS TO THE FIELD ARE ELIGIBLE FOR ACTIVE MEMBER STATUS), AND (B) OTHER HEALTH PROFESSIONALS AT THE DOCTORAL LEVEL (E.G., EPIDEMIOLOGISTS, BIOSTATISTICIANS, PUBLIC HEALTH SPECIALISTS, NURSES, OTHER SCIENTISTS, ETC.) OR INDIVIDUALS WITH EQUIVALENT ACADEMIC RANKS WHO DEVOTE A MAJORITY OF THEIR PROFESSIONAL ACTIVITY TO CANCER PATIENT CARE AND/OR RESEARCH OR EDUCATION IN THE BIOLOGY, DIAGNOSIS, PREVENTION OR TREATMENT OF HUMAN CANCER. 1.B. RIGHTS OF FULL MEMBERS INCLUDE THE RIGHT TO ATTEND MEETINGS, SERVE ON ALL COMMITTEES OF ASCO, HOLD OFFICE IN ASCO, AND VOTE ON THE ELECTION OF ELECTED DIRECTORS, ELECTED OFFICERS AND CERTAIN COMMITTEE MEMBERS, AS WELL AS APPROVE SIGNIFICANT DECISIONS OF THE GOVERNING BODY, SUCH AS AMENDMENT TO THE GOVERNING DOCUMENTS AND DISSOLUTION. 2. EMERITUS MEMBERS. 2.A. EMERITUS MEMBERS ARE FULL, ALLIED PHYSICIAN/DOCTORAL SCIENTIST, INTERNATIONAL CORRESPONDING AND AFFILIATED HEALTH PROFESSIONAL MEMBERS WHO HAVE REQUESTED EMERITUS STATUS AT AGE 65, UPON RETIREMENT OR EARLIER IF PERMANENTLY DISABLED. 2.B. EMERITUS MEMBERS WHO AT THE TIME OF THE REQUEST WERE FULL MEMBERS RETAIN ALL RIGHTS AND PRIVILEGES OF FULL MEMBER STATUS, EXCEPT THE HOLDING OF OFFICE, INCLUDING THE RIGHT TO ATTEND MEETINGS, SERVE ON ALL COMMITTEES OF ASCO, AND VOTE ON THE ELECTION OF ELECTED DIRECTORS, ELECTED OFFICERS, AND CERTAIN COMMITTEE MEMBERS, AS WELL AS APPROVE SIGNIFICANT DECISIONS OF THE GOVERNING BODY, SUCH AS AMENDMENT TO THE GOVERNING DOCUMENTS AND DISSOLUTION. EMERITUS MEMBERS WHO WERE PREVIOUSLY ALLIED PHYSICIAN/DOCTORAL SCIENTIST, INTERNATIONAL CORRESPONDING OR AFFILIATED HEALTH PROFESSIONAL MEMBERS RETAIN ALL THE RIGHTS AND PRIVILEGES OF ALLIED PHYSICIAN/DOCTORAL SCIENTIST, INTERNATIONAL CORRESPONDING OR AFFILIATED HEALTH PROFESSIONAL MEMBER STATUS RESPECTIVELY. 3. HONORARY MEMBERS. 3.A. HONORARY MEMBERS ARE INDIVIDUALS WHO HAVE MADE AN OUTSTANDING CONTRIBUTION TO CLINICAL ONCOLOGY WHO ARE DESIGNATED AS AN HONORARY MEMBER BY THE BOARD OF DIRECTORS. 3.B. RIGHTS OF HONORARY MEMBERS INCLUDE HAVING ALL PRIVILEGES OF FULL MEMBERS, EXCEPT THEY MAY NOT HOLD OFFICE, INCLUDING THE RIGHT TO ATTEND MEETINGS, SERVE ON ALL COMMITTEES OF ASCO, AND VOTE ON THE ELECTION OF ELECTED DIRECTORS, ELECTED OFFICERS, AND CERTAIN COMMITTEE MEMBERS, AS WELL AS APPROVE SIGNIFICANT DECISIONS OF THE GOVERNING BODY, SUCH AS AMENDMENT TO THE GOVERNING DOCUMENTS AND DISSOLUTION.
FORM 990, PART VI, SECTION A, LINE 7A	VOTING MEMBERS OF ASCO ELECT ALL 18 VOTING MEMBERS OF THE ASCO BOARD OF DIRECTORS. THE CATEGORIES OF MEMBERS WHO ARE ELIGIBLE TO VOTE FOR THE ELECTION OF MEMBERS OF THE GOVERNING BODY ARE: FULL MEMBERS, EMERITUS MEMBERS WHO WERE FULL MEMBERS AT THE TIME OF REQUEST FOR EMERITUS MEMBER STATUS, AND HONORARY MEMBERS.
FORM 990, PART VI, SECTION A, LINE 7B	ASCO'S GOVERNING DOCUMENTS MAY ONLY BE AMENDED WITH THE APPROVAL OF THE MEMBERS ENTITLED TO VOTE, AND THE ORGANIZATION MAY ONLY BE DISSOLVED WITH THE APPROVAL OF THE MEMBERS ENTITLED TO VOTE. THE CATEGORIES OF MEMBERS WHO ARE ENTITLED TO VOTE ARE: FULL MEMBERS, EMERITUS MEMBERS WHO WERE FULL MEMBERS AT THE TIME OF REQUEST FOR EMERITUS MEMBER STATUS, AND HONORARY MEMBERS.
FORM 990, PART VI, SECTION B, LINE 11	AN ELECTRONIC COPY OF THE ASCO FORM 990 WAS PROVIDED, THROUGH A SECURE SITE, TO EACH MEMBER OF THE BOARD OF DIRECTORS AND WAS DISCUSSED AT A MEETING OF THE BOARD BEFORE IT WAS FILED. THE ASCO FORM 990 WAS REVIEWED BY THE CHIEF FINANCIAL OFFICER, THE CHIEF EXECUTIVE OFFICER, AND THE VICE PRESIDENT AND GENERAL COUNSEL PRIOR TO FILING.
FORM 990, PART VI, SECTION B, LINE 12C	ASCO MAINTAINS A NUMBER OF WRITTEN CONFLICT OF INTEREST POLICIES AND STANDARDS REGARDING THE DISCLOSURE AND MANAGEMENT OF CONFLICTS OF INTEREST. THESE POLICIES AND STANDARDS COVER ALL ASCO MEMBERS AND EMPLOYEES, DIRECTORS, OFFICERS, COMMITTEE MEMBERS, AND ANY PERSON IN A RELATIONSHIP WITH THESE INDIVIDUALS INVOLVING THE SHARING OF INCOME OR ASSETS (E.G. SPOUSE, DEPENDENT CHILDREN). COVERED INDIVIDUALS ARE ASKED TO DISCLOSE FINANCIAL INTERESTS IN OR OTHER RELATIONSHIPS WITH ENTITIES THAT HAVE RELEVANT COMMERCIAL INTERESTS IN ONCOLOGY, INCLUDING EMPLOYMENT OR LEADERSHIP POSITIONS, CONSULTANT OR ADVISORY ROLES, STOCK OWNERSHIP, HONORARIA, RESEARCH FUNDING, AND SERVICE AS AN EXPERT WITNESS. OFFICERS, DIRECTORS AND KEY EMPLOYEES ARE ALSO REQUIRED TO DISCLOSE SERVICE AS AN OFFICER, DIRECTOR, OR TRUSTEE OF ANY OTHER PROFESSIONAL OR ADVOCACY ORGANIZATION RELATING TO SCIENCE OR HEALTH CARE. COMPLETION OF A DISCLOSURE FORM IS REQUIRED AT THE INITIATION OF SERVICE AND UPDATED ANNUALLY THEREAFTER OR WHEN ANY MATERIAL CHANGES OCCUR. ASCO'S CONFLICT OF INTEREST POLICIES ARE INTENDED TO HELP GUIDE THE MANAGEMENT OF ACTUAL, POTENTIAL, AND PERCEIVED CONFLICTS OF INTEREST THROUGH DISCLOSURE OF FINANCIAL INTERESTS OR OTHER RELATIONSHIPS. WHERE THE NATURE AND EXTENT OF A FINANCIAL RELATIONSHIP SUGGEST DISCLOSURE IS NOT ADEQUATE TO MANAGE A REAL OR POTENTIAL CONFLICT, COVERED INDIVIDUALS ARE REQUIRED TO RECUSE THEMSELVES FROM DECISION MAKING. RECUSAL MAY BE SELF-SELECTED, OR MAY BE REQUESTED BY THE COMMITTEE CHAIR, OFFICER, OR EXECUTIVE-LEVEL STAFF MEMBERS. IN ADDITION, IF ASCO WERE TO CONTEMPLATE ENTERING INTO A TRANSACTION OR ARRANGEMENT THAT MIGHT BENEFIT THE PRIVATE INTEREST OF ANY INTERESTED PERSON (I.E. AN ASCO DIRECTOR, PRINCIPAL OFFICER, OR MEMBER OF AN ASCO COMMITTEE WITH BOARD DELEGATED POWERS WHO HAS A DIRECT OR INDIRECT FINANCIAL INTEREST IN THE TRANSACTION), IT MUST FOLLOW A SPECIFIC PROCEDURE TO MANAGE THE CONFLICT, INCLUDING CONSIDERING ALTERATIVE TRANSACTIONS THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST.
FORM 990, PART VI, SECTION B, LINE 15	COMPENSATION OF CHIEF EXECUTIVE OFFICER (CEO): THE DUTIES OF THE CEO OF ASCO INCLUDE SERVING AS: THE CEO OF ASCO, THE CEO OF ASCO'S NON-PROFIT, 501(C)(3) TAX-EXEMPT RELATED ORGANIZATION, CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (CCF); THE PRESIDENT OF ASCO INSTITUTE FOR QUALITY, LLC (D/B/A QOPI CERTIFICATION PROGRAM AND D/B/A CANCERLINQ); AND THE PRESIDENT OF ASCO LEASING LLC. THE WRITTEN EMPLOYMENT CONTRACT BETWEEN THE CEO AND ASCO ADDRESSES COMPENSATION OF THE CEO. THE COMPENSATION OF THE CEO WAS DETERMINED BY THE ASCO BOARD OF DIRECTORS, FOLLOWING THE REVIEW AND RECOMMENDATION OF THE BOARD COMPENSATION COMMITTEE. THE COMPENSATION COMMITTEE CONSULTED WITH INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE COMPENSATION FOR THE CEO WAS REASONABLE. THE REVIEW,RECOMMENDATION, AND DETERMINATION OF THE CEO'S COMPENSATION BASED ON THE ABOVE DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2013. VICE PRESIDENT/GENERAL COUNSEL: THE COMPENSATION OF THE VICE PRESIDENT/GENERAL COUNSEL (VP/GC) WAS CONSIDERED AND APPROVED BY THE BOARD COMPENSATION COMMITTEE, AFTER RECEIVING THE RECOMMENDATION OF THE CEO AND CONSULTING WITH INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT AS FOLLOWS. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE COMPENSATION FOR THE VP/GC WAS REASONABLE. THE WRITTEN EMPLOYMENT CONTRACT BETWEEN THE VP/GC AND ASCO ADDRESSES COMPENSATION OF THE VP/GC. THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE VP/GC BASED ON THE ABOVE DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2013. CHIEF FINANCIAL OFFICER (CFO): THE COMPENSATION OF THE CHIEF FINANCIAL OFFICER (CFO) WAS CONSIDERED AND APPROVED BY THE BOARD COMPENSATION COMMITTEE, AFTER RECEIVING THE RECOMMENDATION OF THE CEO AND CONSULTING WITH INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT AS FOLLOWS. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE PROPOSED COMPENSATION FOR THE CFO WAS REASONABLE. THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE CFO BASED ON THE ABOVE DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2013. EXECUTIVE DIRECTOR OF THE CONQUER CANCER FOUNDATION OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (CCF): THE EXECUTIVE DIRECTOR OF CCF IS AN EMPLOYEE OF ASCO. THE ASCO BOARD COMPENSATION COMMITTEE CONSIDERED AND APPROVED THE COMPENSATION OF THE EXECUTIVE DIRECTOR OF CCF AFTER RECEIVING THE RECOMMENDATION OF THE CEO AND CONSULTING WITH INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT AS FOLLOWS. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE COMPENSATION OF THE EXECUTIVE DIRECTOR OF CCF WAS REASONABLE. THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE EXECUTIVE DIRECTOR OF CCF BASED ON THE ABOVE DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2013. SENIOR DIRECTOR, INTEGRATED MEDIA AND TECHNOLOGY: THE COMPENSATION OF THE SENIOR DIRECTOR, INTEGRATED MEDIA AND TECHNOLOGY WAS CONSIDERED AND APPROVED BY THE BOARD COMPENSATION COMMITTEE, AFTER RECEIVING THE RECOMMENDATION OF THE CEO AND CONSULTING WITH INDEPENDENT LEGAL COUNSEL AND ITS INDEPENDENT COMPENSATION CONSULTANT AS FOLLOWS. THE INDEPENDENT COMPENSATION CONSULTANT COLLECTED AND REPORTED ON COMPARABLE MARKET DATA (INCLUDING DATA ON COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS) AND PROVIDED ITS OPINION THAT THE COMPENSATION OF THE SENIOR DIRECTOR, INTEGRATED MEDIA AND TECHNOLOGY WAS REASONABLE. THE CONSIDERATION AND APPROVAL OF THE COMPENSATION OF THE SENIOR DIRECTOR, INTEGRATED MEDIA AND TECHNOLOGY BASED ON THE ABOVE DESCRIBED PROCESS WERE MOST RECENTLY UNDERTAKEN IN 2013.
FORM 990, PART VI, SECTION C, LINE 19	ASCO'S GOVERNING DOCUMENTS ARE AVAILABLE TO THE PUBLIC FROM ASCO UPON REQUEST. ASCO'S CERTIFICATE OF INCORPORATION IS ALSO AVAILABLE TO THE PUBLIC THROUGH THE SECRETARY OF STATE OF NEW YORK. ASCO'S CONFLICT OF INTEREST POLICY IS POSTED ON ASCO'S WEBSITE, AND WAS PUBLISHED IN THE APRIL 2014 EDITION OF JOURNAL OF CLINICAL ONCOLOGY (THE EDITION IS AVAILABLE TO THE PUBLIC FOR FREE). ALL OF ASCO'S CONFLICT OF INTEREST POLICIES ARE PUBLICLY AVAILABLE. ASCO'S ANNUAL REPORT IS POSTED ON ASCO'S WEBSITE AND IS AVAILABLE TO THE PUBLIC FROM ASCO UPON REQUEST.
FORM 990, PART VI, SECTION B, LINE 10B:	ALTHOUGH ASCO HAS STATE AND REGIONAL AFFILIATES THROUGH ITS STATE AND REGIONAL AFFILIATE PROGRAM, ASCO DOES NOT HAVE THE LEGAL AUTHORITY TO EXERCISE SUPERVISION AND CONTROL OVER THEM AND EACH AFFILIATE IS A SEPARATELY INCORPORATED LEGAL ENTITY THAT IS RESPONSIBLE FOR ITS OWN FISCAL MANAGEMENT. AFFILIATES MAY NOT ACT ON BEHALF OF ASCO AND ARE PROHIBITED FROM ANY ACTION THAT MIGHT IMPLY AN AGENCY RELATIONSHIP. AFFILIATES MAY NOT BIND ASCO TO ANY CONTRACT WITH A THIRD PARTY. ASCO'S STATE AND REGIONAL AFFILIATE PROGRAM IS DESIGNED TO ASSIST STATE AND REGIONAL SOCIETIES IN ADDRESSING THE PRACTICAL ISSUES FACING PHYSICIANS WHO CARE FOR PEOPLE WITH CANCER AND TO FACILITATE AND ENCOURAGE INVOLVEMENT IN ASCO'S PUBLIC POLICY INITIATIVES. EACH AFFILIATE HAS A VOTING REPRESENTATIVE ON THE ASCO STATE AFFILIATE COUNCIL, WHICH IS INTENDED TO ADDRESS THE PRACTICE OF ONCOLOGY, WITH A PARTICULAR FOCUS ON REIMBURSEMENT FOR, ACCESS TO, AND QUALITY OF MEDICAL ONCOLOGY SERVICES. THROUGH PARTICIPATION IN THE ASCO STATE AFFILIATE COUNCIL, AFFILIATES HAVE A ROLE IN THE DEVELOPMENT OF PUBLIC POLICY POSITIONS AT THE NATIONAL LEVEL AND ALSO RECEIVES INPUT REGARDING STATE AND REGIONAL ISSUES AFFECTING ONCOLOGY. STATE AND REGIONAL SOCIETIES INTERESTED IN BEING AFFILIATES MUST SUBMIT AN APPLICATION TO ASCO THAT, AMONG OTHER THINGS, REQUIRES THEM TO DEMONSTRATE THAT THEY ARE VALIDLY INCORPORATED UNDER STATE LAW, HAVE IN PLACE GOVERNANCE PRACTICES AND PROCEDURES (BYLAWS, OFFICERS, DIRECTORS, ELECTIONS, MEETINGS, AND RESPONSIBLE FISCAL MANAGEMENT), AND HAVE PHYSICIAN MEMBERSHIP REQUIREMENTS THAT ARE CONSISTENT WITH ASCO'S STANDARDS. ASCO PROVIDES STATE AFFILIATES WITH A VARIETY OF ASSISTANCE, INCLUDING ASCO POLICY ANALYSES, ACCESS TO ASCO STAFF ON MATTERS OF INTEREST TO STATE AFFILIATES, AND ASSISTANCE WITH MEDIA AND OUTREACH.
FORM 990, PART IX, LINE 11G	COMMISSIONS: PROGRAM SERVICE EXPENSES 2,767,062. MANAGEMENT AND GENERAL EXPENSES 50,675. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 2,817,737. PUBLIC RELATIONS COORDINATOR: PROGRAM SERVICE EXPENSES 1,064,805. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 1,064,805. OTHER PROFESSIONAL SERVICES: PROGRAM SERVICE EXPENSES 5,924,623. MANAGEMENT AND GENERAL EXPENSES 1,105,822. FUNDRAISING EXPENSES 35,293. TOTAL EXPENSES 7,065,738.
FORM 990, PART XI, LINE 9:	GAIN ON VALUE OF INTEREST RATE SWAP 8,053,899.

Schedule R IRS990ScheduleR

Id Disregarded Entities IdDisregardedEntitiesGrp (2 entries)

Address Line1USAddress/AddressLine1	CityUSAddress/City	StateUSAddress/State	ZIP CodeUSAddress/ZIPCode	EINEIN	Primary ActivitiesPrimaryActivitiesTxt	Legal Domicile StateLegalDomicileStateCd	Total IncomeTotalIncomeAmt	End Of Year AssetsEndOfYearAssetsAmt	Business Name Line1DirectControllingEntityName/BusinessNameLine1
ASCO INSTITUTE FOR QUALITY LLC (FMRLY INST CLINICAL EXCELLENCE)
2318 MILL ROAD	ALEXANDRIA	VA	22314	271629211	QOPI CERTIFICATION PROGAM	VA	$233,885	$399,873	AMERICAN SOCIETY OF CLINICAL ONCOLOGY
ASCO LEASING LLC
2318 MILL ROAD	ALEXANDRIA	VA	22314	273378225	RENTAL OF 5TH FLOOR	VA	$971,631	$318,605	AMERICAN SOCIETY OF CLINICAL ONCOLOGY

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp

Disregarded Entity Name DisregardedEntityName

Field	Value	IRS element (for citing)
Business Name Line1	CONQUER CANCER FOUNDATION OF ASCO (CCF)	BusinessNameLine1

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	2318 MILL ROAD	AddressLine1
City	ALEXANDRIA	City
State	VA	State
ZIP Code	22314	ZIPCode

Field	Value	IRS element (for citing)
EIN	311667995	EIN
Primary Activities	DEDICATED TO CONQUERING CANCER WORLDWIDE BY FUNDING RESEARCH	PrimaryActivitiesTxt
Legal Domicile State	VA	LegalDomicileStateCd
Exempt Code Section	501 (C)(3)	ExemptCodeSectionTxt
Public Charity Status	509 (A)(1)	PublicCharityStatusTxt
Controlled Organization	Yes (1)	ControlledOrganizationInd

Field	Value	IRS element (for citing)
Receipt Of Int Annts Rnts Rylts	Yes (1)	ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth Org	Yes (1)	GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth Org	Yes (1)	GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org	0	LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org	Yes (1)	LoansOrGuaranteesFromOthOrgInd
Div Related Organization	0	DivRelatedOrganizationInd
Asset Sale To Other Org	0	AssetSaleToOtherOrgInd
Asset Purchase From Other Org	0	AssetPurchaseFromOtherOrgInd
Asset Exchange	0	AssetExchangeInd
Rental Of Facilities To Oth Org	Yes (1)	RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org	0	RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org	0	PerformOfServicesForOthOrgInd
Perform Of Services By Other Org	Yes (1)	PerformOfServicesByOtherOrgInd
Sharing Of Facilities	Yes (1)	SharingOfFacilitiesInd
Paid Employees Sharing	Yes (1)	PaidEmployeesSharingInd
Reimbursement Paid To Other Org	Yes (1)	ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org	Yes (1)	ReimbursementPaidByOtherOrgInd
Transfer To Other Org	0	TransferToOtherOrgInd
Transfer From Other Org	0	TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp (9 entries)

Transaction TypeTransactionTypeTxt	InvolvedInvolvedAmt	Method Of Amount DeterminationMethodOfAmountDeterminationTxt
CCF
A	$295,032	FMV
CCF
B	$140,000	FMV
CCF
C	$8,371,709	FMV
CCF
E	$64,000,000	FMV
CCF
J	$295,032	FMV
CCF
M	$1,740,661	FMV
CCF
O	$3,085,127	FMV
CCF
P	$2,199,996	V
CCF
Q	$5,062,919	FMV